Applications Guide

Real-Time PCR
Applications Guidetable of contents

Table of Contents
1. Overview of Real-Time PCR2

1.1 Key Concepts of Real-Time PCR2

1.1.1 What Is Real-Time PCR?

2

1.1.2 How Real-Time PCR Works3

1.1.3 Hallmarks of an Optimized qPCR Assay

4

2. Getting Started

8

2.1 General Considerations8

2.2 Experimental Design Considerations for qPCR

92.2.1 Singleplex or Multiplex?

92.2.2 Chemistry Selection

92.2.2.1 DNA-Binding Dyes (SYBR Green I)

10

2.2.2.2 Fluorescent Primer- and Probe-Based Chemistries

12

2.3 Design and Optimization of SYBR Green I Reactions

19

2.3.1 Primer and Amplicon Design19

2.3.2 Assay Validation and Optimization

20

2.3.2.1 Annealing Temperature Optimization

20

2.3.2.2 Assay Performance Evaluation Using Standard Curves

22

2.4 Design and Optimization of TaqMan Probe Reactions

23

2.4.1 Primer and Probe Design23

2.4.2 Assay Validation and Optimization

24

3. Multiplexing Considerations28

3.1 Primer and Probe Design for Multiplexing28

3.2 Selection of Reporters and Quenchers for Multiplexing29

3.3 Optimization of Individual Assays Before Multiplexing29

3.4 Validation of Multiplex Assays

29

3.5 Optimization of Multiplex Assays

30table of contents i

table of contents

4. Real-Time qPCR Data Analysis

34

4.1 Absolute Quantification

35

4.1.1 When Should Absolute Quantification Be Used?
4.1.2 Absolute Quantification Using a Standard Curve
4.2 Relative Quantification

35
35
37

4.2.1 When Should Relative Quantification Be Used?

37

4.2.2 Relative Quantification Normalized Against Unit Mass

38

4.2.3 Relative Quantification Normalized to a Reference Gene

40

4.2.3.1 The 2–∆∆CT (Livak) Method

41

4.2.3.2 The ∆CT Method Using a Reference Gene

42

4.2.3.3 The Pfaffl Method

43

5. Gene Expression Analysis

46

5.1 Experimental Design

46

5.2 RNA Isolation

47

5.2.1 Sample Collection

47

5.2.2 RNA Extraction

48

5.2.3 Analyzing Nucleic Acid Quantity and Quality48

5.3 cDNA Template Preparation (Reverse Transcription)49

5.4 qPCR Assay Development

50

5.5 Experimentation

51

5.5.1 Reaction Components for Multiplex Assay51

5.5.2 Cycling Protocol

51

5.6 Gene Expression Data Analysis

52

6. Genotyping/Allelic Discrimination

54

6.1 Experimental Design55

6.2 Primer and Probe Design Using TaqMan Probes

56

6.3 DNA Extraction and Sample Preparation

57

6.4 Reaction Components When Using TaqMan Probes

58

6.5 Optimization

59

6.6 Cycling Protocol Using TaqMan Probes

59

6.7 Allelic Discrimination Data Analysis

59

6.7.1 Validation of Allelic Discrimination Assay59

6.7.2 Genotype Assignments

72

table of contents ii

table of contents

7. Genetically Modified Organism (GMO) Detection76

7.1 Experimental Design77

7.2 DNA Extraction and Sample Preparation for GMO Detection

77

7.3 GM Soy Detection Using a Singleplex SYBR Green I qPCR Assay78

7.3.1 Reaction Components

78

7.3.2 Cycling Protocol

79

7.3.3 Data Analysis

79

7.4 GM Soy Detection Using a Multiplex TaqMan qPCR Assay81

7.4.1 Reaction Components

82

7.4.2 Cycling Protocol

82

7.4.3 Data Analysis

82

8. Product Guide

85

table of contents iii

Overview of
Real-Time PCR
Key Concepts of Real-Time PCR

2What Is Real-Time PCR?

2

How Real-Time PCR Works

3

Hallmarks of an Optimized qPCR Assay4overview of real-time PCR
key concepts of real-time PCR

1. Overview of
Real-Time PCR
Nucleic acid amplification and detection are among the most valuable techniques
used in biological research today. Scientists in all areas of research — basic
science, biotechnology, medicine, forensic science, diagnostics, and more —rely on these methods for a wide range of applications. For some applications,
qualitative nucleic acid detection is sufficient. Other applications, however, demanda quantitative analysis. Choosing the best method for your application requires abroad knowledge of available technology.
This guide provides an introduction to many of the technical aspects of real-time
PCR. It includes guidelines for designing the best real-time PCR assay for yourexperiments and explains how real-time PCR data are used in various applications.
In Sections 5–7, we present sample protocols and data that demonstrate the useof real-time PCR in specific applications, namely, gene expression analysis, allelicdiscrimination, and genetically modified organism (GMO) detection.
We hope that this guide will give you the information you need to bring thispowerful technique to your bench — and beyond.

1.1 Key Concepts of Real-Time PCR
1.1.1 What Is Real-Time PCR?
In conventional PCR, the amplified product, or amplicon, is detected by an
end-point analysis, by running DNA on an agarose gel after the reaction has
finished. In contrast, real-time PCR allows the accumulation of amplified product tobe detected and measured as the reaction progresses, that is, in “real time”.
Real-time detection of PCR products is made possible by including in the reaction
a fluorescent molecule that reports an increase in the amount of DNA with aproportional increase in fluorescent signal. The fluorescent chemistries employed
for this purpose include DNA-binding dyes and fluorescently labeled sequencespecific primers or probes. Specialized thermal cyclers equipped with fluorescence
detection modules are used to monitor the fluorescence as amplification occurs.
The measured fluorescence reflects the amount of amplified product in each cycle.

2© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guideoverview of real-time PCR
key concepts of real-time PCR

The main advantage of real-time PCR over conventional PCR is that real-time PCR
allows you to determine the starting template copy number with accuracy andhigh sensitivity over a wide dynamic range. Real-time PCR results can either bequalitative (presence or absence of a sequence) or quantitative (number of copies
of DNA). Real-time PCR that is quantitative is also known as qPCR. In contrast,
conventional PCR is at best semi-quantitative. Additionally, real-time PCR data canbe evaluated without gel electrophoresis, resulting in reduced experiment time andincreased throughput. Finally, because reactions are run and data are evaluated ina closed-tube system, opportunities for contamination are reduced and the needfor postamplification manipulation is eliminated.

1.1.2 How Real-Time PCR WorksTo understand how real-time PCR works, let’s start by examining a sample
amplification plot (Figure 1.1). In this plot, the PCR cycle number is shown on thex-axis, and the fluorescence from the amplification reaction, which is proportional
to the amount of amplified product in the tube, is shown on the y-axis.
The amplification plot shows two phases, an exponential phase followed by anonexponential plateau phase. During the exponential phase, the amount of
PCR product approximately doubles in each cycle. As the reaction proceeds,
however, reaction components are consumed, and ultimately one or more of thecomponents becomes limiting. At this point, the reaction slows and enters theplateau phase (cycles 28–40 in Figure 1.1).

Exponential phase

Fluorescence

0.3

Nonexponential
plateauphase

0.2

CT value
0.1

Threshold line
0
0

10

20

30

40

Cycle
Fig. 1.1. Amplification plot. Baseline-subtracted fluorescence is shown.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide3

overview of real-time PCR
key concepts of real-time PCR

Initially, fluorescence remains at background levels, and increases in fluorescenceare not detectable (cycles 1–18 in Figure 1.1) even though product accumulates
exponentially. Eventually, enough amplified product accumulates to yield adetectable fluorescent signal. The cycle number at which this occurs is called thethreshold cycle, or CT. Since the CT value is measured in the exponential phasewhen reagents are not limited, real-time qPCR can be used to reliably andaccurately calculate the initial amount of template present in the reaction.
The CT of a reaction is determined mainly by the amount of template present at
the start of the amplification reaction. If a large amount of template is present at
the start of the reaction, relatively few amplification cycles will be required toaccumulate enough product to give a fluorescent signal above background.
Thus, the reaction will have a low, or early, CT. In contrast, if a small amount oftemplate is present at the start of the reaction, more amplification cycles will be
required for the fluorescent signal to rise above background. Thus, the reaction will
have a high, or late, CT. This relationship forms the basis for the quantitative aspectof real-time PCR. Details of how CT values are used to quantify a sample arepresented in Section 4.

1.1.3 Hallmarks of an Optimized qPCR Assay
Since real-time quantification is based on the relationship between initial template
amount and the CT value obtained during amplification, an optimal qPCR assay is
absolutely essential for accurate and reproducible quantification of your sample.
The hallmarks of an optimized qPCR assay are:• Linear standard curve (R2 > 0.980 or r > |–0.990|)• High amplification efficiency (90–105%)• Consistency across replicate reactions
A powerful way to determine whether your qPCR assay is optimized is to run
serial dilutions of a template and use the results to generate a standard curve.
The template used for this purpose can be a target with known concentration(e.g., nanograms of genomic DNA or copies of plasmid DNA) or a sample ofunknown quantity (e.g., cDNA). The standard curve is constructed by plotting
the log of the starting quantity of template (or the dilution factor, for unknown
quantities) against the CT value obtained during amplification of each dilution.
The equation of the linear regression line, along with Pearson’s correlation
coefficient (r) or the coefficient of determination (R2), can then be used to evaluate
whether your qPCR assay is optimized.

4© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guideoverview of real-time PCR
key concepts of real-time PCR

Ideally, the dilution series will produce amplification curves that are evenly spaced,as shown in Figure 1.2 A. If perfect doubling occurs with each amplification cycle,
the spacing of the fluorescence curves will be determined by the equation 2n =dilution factor, where n is the number of cycles between curves at the fluorescencethreshold (in other words, the difference between the CT values of the curves).
For example, with a 10-fold serial dilution of DNA, 2n = 10. Therefore, n = 3.32,
and the CT values should be separated by 3.32 cycles. Evenly spaced amplification
curves will produce a linear standard curve, as shown in Figure 1.2 B. The equation
and r value of the linear regression line are shown above the plot.
The r or R2 value of a standard curve represents how well the experimental data
fit the regression line, that is, how linear the data are. Linearity, in turn, gives ameasure of the variability across assay replicates and whether the amplification
efficiency is the same for different starting template copy numbers. A significant
difference in observed CT values between replicates will lower the r or R2 value.
You should strive for an r whose absolute value is >0.990 or an R2 value >0.980 foryour qPCR reactions.
A

B

Fig. 1.2. Generating a standard curve to assess reaction optimization. A standard curve was generatedusing a 10-fold dilution of a template amplified on the iCycler iQ® real-time system. Each dilution was assayed intriplicate. A, Amplification curves of the dilution series. B, Standard curve with the CT plotted against the log ofthe starting quantity of template for each dilution. The equation for the regression line and the r value are shown
above the graph. The calculated amplification efficiency was 95.4%.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide5

overview of real-time PCR
key concepts of real-time PCR

Amplification efficiency, E, is calculated from the slope of the standard curve using
the following formula:E = 10–1/slope
Ideally, the amount of PCR product will perfectly double during each cycle ofexponential amplification; that is, there will be a 2-fold increase in the number ofcopies with each cycle. This translates to a reaction efficiency of 2. Using anefficiency equal to 2 in the equation above, 2 = 10–1/slope, indicates that the optimalslope of the standard curve will be –3.32. Note that the absolute value of the slope
is the same as the ideal spacing of the fluorescent traces described above.
Amplification efficiency is also frequently presented as a percentage, that is,
the percent of template that was amplified in each cycle. To convert E into
a percentage:% Efficiency = (E – 1) x 100%
For an ideal reaction, % Efficiency = (2 – 1) x 100% = 100%.
For the example shown in Figure 1.2:
E = 10–(1/–3.436) = 1.954% Efficiency = (1.954 – 1) x 100% = 95.4%
At the end of each cycle, the amplicon copy number increased 1.954-fold,or 95.4% of the template was amplified.
An efficiency close to 100% is the best indicator of a robust, reproducible assay.
In practice, you should strive for an amplification efficiency of 90–105%. Low
reaction efficiencies may be caused by poor primer design or by suboptimal
reaction conditions. Reaction efficiencies >100% may indicate pipetting error inyour serial dilutions or coamplification of nonspecific products, such as primerdimers. When using the method described above to determine amplification
efficiency, the presence of inhibitor can also result in an apparent increase inefficiency. This is because samples with the highest concentration of template also
have the highest level of inhibitors, which cause a delayed CT, whereas samples
with lower template concentrations have lower levels of inhibitors, so the CT is
minimally delayed. As a result, the absolute value of the slope decreases and thecalculated efficiency appears to increase. If your reaction efficiency is <90% or>105%, we suggest that you modify your assay by redesigning your primers andprobes. See Sections 2.3 and 2.4 for primer and probe design guidelines.

6© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

Getting Started
General Considerations

8

Experimental Design Considerations for qPCR

9Singleplex or Multiplex?

9

Chemistry Selection

9

DNA-Binding Dyes (SYBR Green I)

10

Fluorescent Primer- and Probe-Based Chemistries

12

Design and Optimization of SYBR Green I Reactions

19

Primer and Amplicon Design

19

Assay Validation and Optimization

20

Annealing Temperature Optimization

20

Assay Performance Evaluation Using Standard Curves

22

Design and Optimization of TaqMan Probe Reactions

23

Primer and Probe Design

23

Assay Validation and Optimization

24

getting started
general considerations

2. Getting Started
Now that we have introduced the concepts behind real-time qPCR, we can delve
into more practical matters. In this chapter, we offer recommendations for setting
up your real-time qPCR assays, including basic laboratory techniques (Section 2.1),
basic experimental design and reaction components (Section 2.2), deciding
between singleplex vs. multiplex assays (Section 2.2.1), and selecting a real-timechemistry (Section 2.2.2). We also provide more detailed instructions for setting
up qPCR reactions using the two most popular chemistries, SYBR Green I(Section 2.3) and TaqMan (Section 2.4).

2.1 General Considerations
Proper laboratory technique is an important yet often overlooked step toward
successful real-time PCR. For optimal results, you should minimize the potential forcross-contamination between samples and prevent carryover of nucleic acids fromone experiment to the next. The following precautions can help you avoid
contamination problems:• Wipe down workstations with dilute solutions of bleach or with commerciallyavailable decontamination solutions• Prepare samples in a designated clean room, hood, or benchtop workstationequipped with a UV lamp. Ideally, this should be located in a different areafrom the thermal cycler. Take care to avoid contaminating the area with plasmids
or amplicons; never bring postamplification products into the designatedclean area
• Change gloves frequently during sample preparation and reaction setup• Use shaftguard pipets and aerosol-barrier pipet tips
• Clean pipets frequently with a dilute solution of bleach• Use PCR-grade water and reagents dedicated for PCR use only
• Use screw-capped tubes for dilutions and reaction setup
In addition to taking the above precautions, you should always prepare ano-template control for your PCR assays to verify that no contamination has
occurred. Furthermore, use a hot-start polymerase to prevent indiscriminate
amplification before the reaction begins.

8© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started
experimental design considerations

To minimize statistical variation in experimental results, prepare master mixes for
replicate reactions whenever possible. We recommend running all samples in
triplicate. Minimize repeated freezing and thawing by preparing small aliquots ofstock reagent before first use.

2.2 Experimental Design Considerations
for qPCR
The first step in designing a real-time PCR experiment is to decide on the best typeof assay for the experiment of interest. Should a singleplex or multiplex assay beused? What type of real-time chemistry should one employ? In the following
sections, we describe each type of assay and provide guidelines on how to choose
the best type of assay for your experiment.

2.2.1 Singleplex or Multiplex?
Both practical and scientific reasons might compel you to try multiplexing, theamplification of more than one target in a single reaction tube. Currently, it ispossible to amplify and quantify as many as five targets in a single tube, dependingon the features of your real-time PCR instrument. Multiplexing confers the following
advantages over singleplex reactions:• Reduction in the amount of starting template required, which is important when
the amount of starting material is limited• Reduction in false negatives, if a control target is amplified within each sample• Increased laboratory throughput with a concomitant reduction in reagent costs• Minimization of sample handling and associated opportunities for laboratory
contamination
If none of these considerations are important for your assays, then singleplex
reactions are sufficient. Practical advice on how to set up and optimize multiplex
qPCR reactions is given in Section 3.

2.2.2 Chemistry Selection
A key step in designing a qPCR assay is selecting the chemistry to monitor theamplification of the target sequence. The variety of fluorescent chemistries available
can be categorized into two major types: 1) DNA-binding dyes (SYBR Green I),
and 2) dye-labeled, sequence-specific oligonucleotide primers or probes (molecularbeacons and TaqMan, hybridization, and Eclipse probes, and Amplifluor, Scorpions,
LUX, and BD QZyme primers). The most commonly used chemistries for real-time PCR
are the DNA-binding dye SYBR Green I and TaqMan hydrolysis probes. We provide an
overview of these different types of fluorescent chemistries in Sections 2.2.2.1–2.2.2.2.
© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

9getting started
experimental design considerations

The chemistry you select for your qPCR assay depends on your application,
whether you’re performing singleplex or multiplex reactions, and cost considerations.
In general, for low-throughput, singleplex experiments, DNA-binding dyes may be
preferable because these assays are easier to design, are faster to set up, andare initially more cost-effective. For high-throughput experiments, however, afluorescent primer- or probe-based assay (singleplex or multiplex) may be moredesirable because the initial cost can be spread over many experiments and themultiplex capability can reduce assay time. Multiplex assays require the use of afluorescent primer- or probe-based chemistry, because the lack of specificity of
DNA-binding dyes makes them incompatible with quantitative multiplex assays.

2.2.2.1 DNA-Binding Dyes (SYBR Green I)
The most commonly used DNA-binding dye for real-time PCR is SYBR Green I,
which binds nonspecifically to double-stranded DNA (dsDNA). SYBR Green I
exhibits little fluorescence when it is free in solution, but its fluorescence increases
up to 1,000-fold when it binds dsDNA (Figure 2.1). Therefore, the overall
fluorescent signal from a reaction is proportional to the amount of dsDNA present,
and will increase as the target is amplified.

Unbound SYBR Green I
Bound SYBR Green I

PCR

Fig. 2.1. DNA-binding dyes in real-time PCR. Fluorescence dramatically increases when the dyemolecules bind to dsDNA.

10© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started
experimental design considerations

The advantages of using dsDNA-binding dyes include simple assay design(only two primers are needed; probe design is not necessary), ability to test multiple
genes quickly without designing multiple probes (e.g., for validation of gene
expression data from many genes in a microarray experiment), lower initial cost(probes cost more), and the ability to perform a melt-curve analysis to check the
specificity of the amplification reaction.
Melt-curve analysis can be used to identify different reaction products, including
nonspecific products. After completion of the amplification reaction, a melt curve isgenerated by increasing the temperature in small increments and monitoring thefluorescent signal at each step. As the dsDNA in the reaction denatures (i.e., as
the DNA “melts”), the fluorescence decreases. The negative first derivative of thechange in fluorescence is plotted as a function of temperature. A characteristic
peak at the amplicon’s melting temperature (Tm, the temperature at which 50% of
the base pairs of a DNA duplex are separated) distinguishes it from other products
such as primer-dimers, which melt at different temperatures. An example of thisis shown in Figure 2.2. The melt peak with a Tm of 89°C represents the specificproduct, and corresponds to the upper band in lanes 2 and 3 on the gel. The peakwith a Tm of 78°C represents the nonspecific product, and corresponds to thelower band in lanes 2 and 3 on the gel.
The major drawback of DNA-binding dyes is their lack of specificity, that is,
DNA-binding dyes bind to any dsDNA. As a result, the presence of nonspecificproducts in a real-time PCR reaction may contribute to the overall fluorescence andaffect the accuracy of quantification. Another consequence is that DNA-bindingdyes cannot be used for multiplex reactions because fluorescent signals fromdifferent amplicons cannot be distinguished. Instead, you can set up parallel
reactions to examine multiple genes, such as a gene of interest and reference
gene, in a real-time PCR assay with SYBR Green I.
A

B

Fig. 2.2. Melt-curve analysis of reaction product from a SYBR Green I assay. The melt-curve analysis
function of real-time instruments can be used to distinguish specific products from nonspecific products.
A, The negative first derivative of the change in fluorescence is plotted as a function temperature.
The two peaks indicate the Tm values of two PCR products. B, Gel analysis of the qPCR products.
Lane 1, AmpliSize® 50–2,000 base pairs (bp) molecular ruler; lanes 2 and 3, two replicates of qPCR
product from the reaction shown in (A). The two PCR products are revealed by separate bands in the gel.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

11getting started
experimental design considerations

2.2.2.2 Fluorescent Primer- and Probe-Based Chemistries
Many fluorescent primer- and probe-based chemistries have been devised andare available from different commercial vendors. The most commonly used probebased chemistries, TaqMan probes and molecular beacons, are discussed in detailbelow. Brief descriptions of other fluorescent primer- and probe-based chemistries,
including Eclipse probes and Amplifluor, Scorpions, LUX, and BD QZyme primers,
are also presented below.
Primer- and probe-based detection chemistries share some common features.
In general, these chemistries take advantage of fluorescence resonance energy
transfer (FRET), or some other form of fluorescence quenching, to ensure thatspecific fluorescence is detected only in the presence of amplified product.
The primer or target-specific oligonucleotide probe is labeled with a reporter
fluorophore; but in most cases, the oligonucleotide is designed so thatfluorescence is quenched when the specific target is unavailable. Usually this isaccomplished by attaching a quencher molecule to the probe, and devising somemechanism by which the reporter and quencher are separated when the probe
binds to its specific target. The details of how each chemistry achieves thisseparation will be described in the following sections.
In real-time PCR, fluorescent primers and probes offer two main advantages
over DNA-binding dyes. First, they specifically detect the target sequence sononspecific products do not affect the accuracy of quantification. Second, they
allow multiplex reactions to be performed.
TaqMan Assays
TaqMan assays employ a sequence-specific, fluorescently labeled oligonucleotide
probe called the TaqMan probe, in addition to the sequence-specific primers.
Figure 2.3 illustrates how TaqMan assays work. Also known as the 5'-nucleaseassay, the TaqMan assay exploits the 5'-exonuclease activity of certain
thermostable polymerases, such as Taq or Tth. The probe contains a fluorescentreporter at the 5' end and a quencher at the 3' end. When intact, the fluorescenceof the reporter is quenched due to its proximity to the quencher. During the
combined annealing/extension step of the amplification reaction, the probehybridizes to the target and the dsDNA-specific 5'—>3' exonuclease activity of
Taq or Tth cleaves off the reporter. As a result, the reporter is separated from thequencher, and the resulting fluorescence signal is proportional to the amount of
amplified product in the sample. One commonly used fluorescent reporterquencher pair is fluorescein (FAM, which emits green fluorescence) and Black
Hole Quencher 1. For more information about suitable reporter-quencher pairs, see
Table 2.1.
The main advantages of using TaqMan probes include high specificity, a highsignal-to-noise ratio, and the ability to perform multiplex reactions. The
disadvantages are that the initial cost of the probe may be high and the assay
design may not be trivial. See Section 2.4.1 for details on TaqMan assay design.
12© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started
experimental design considerations

R

Q

During annealing, the TaqMan probe binds to thetarget sequence
Extension
R
Q

During extension, the probe is partially displaced
and the reporter is cleaved. The free reporter
fluoresces

R

Q

R

Reporter

Q

QuencherFig. 2.3. TaqMan assay.

Molecular Beacons
In addition to two sequence-specific primers, molecular beacon assays employ asequence-specific, fluorescently labeled oligonucleotide probe called a molecularbeacon, which is a dye-labeled oligonucleotide (25–40 nt) that forms a hairpin
structure with a stem and a loop (Figure 2.4). A fluorescent reporter is attached to
the 5' end of the molecular beacon and a quencher is attached to the 3' end. The
loop is designed to hybridize specifically to a 15–30 nucleotide section of the target
sequence. On either side of the loop are 5–6 nt that are complementary to eachother, and form a stem structure that serves to bring the reporter and quencher
together. In the hairpin structure, no fluorescence is detected from the reporter
due to its physical proximity to the quencher. During the annealing step of theamplification reaction, the molecular beacon binds to its target sequence,
separating the reporter and quencher such that the reporter is no longer quenched.
Unlike TaqMan assays, molecular beacons are displaced but not destroyed during
amplification, because a DNA polymerase lacking the 5' exonuclease activity isused. The amount of fluorescence emitted by the reporter on the molecular beacon
is proportional to the amount of target in the reaction.
Molecular beacons have some advantages over other chemistries. They are highly
specific, can be used for multiplexing, and if the target sequence does not matchthe beacon sequence exactly, hybridization and fluorescence will not occur —a desirable quality for allelic discrimination experiments.
The main disadvantage of using molecular beacons lies in their design. The stemof the hairpin must be strong enough that the molecule will not spontaneously foldinto non-hairpin conformations that result in unintended fluorescence. At the sametime, the stem of the hairpin must not be too strong, or the beacon may notproperly hybridize to the target.
© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

13

getting started
experimental design considerations

R

R

Molecular beacons are hairpin probes with
reporter and quencher

Q

Q

During annealing, the probe binds to thetarget sequence to separate reporter andquencher. The reporter fluoresces

R

Reporter

Q

QuencherFig. 2.4. Molecular beacons.

Other Chemistries
Hybridization probe assays employ two sequence-specific oligonucleotide
probes, in addition to two sequence-specific primers. The two probes are designed
to bind to adjacent sequences in the target, as illustrated in Figure 2.5. The firstprobe carries a donor dye at its 3' end, while the second carries an acceptor dye atits 5' end. The donor and the acceptor dyes are selected such that the emission
spectrum of the donor dye overlaps significantly with the excitation spectrum of theacceptor dye, while the emission spectrum of the donor dye is spectrally separated
from the emission spectrum of the acceptor dye. Excitation is performed at awavelength specific to the donor dye, and the reaction is monitored at the emission
wavelength of the acceptor dye. During the annealing step of PCR, the probes
hybridize to their target sequences in a head-to-tail arrangement. This brings thefluorescent molecules into proximity, allowing fluorescence resonance energy
transfer from donor to acceptor. The increasing amount of acceptor fluorescenceis proportional to the amount of amplicon present.
R2

R1 Donor fluorophore

R1
R2

Acceptor fluorophore

R1 R2During annealing, the two probes bindto the target in a head-to-tail orientation.
The acceptor fluorophore fluoresces

Fig. 2.5. Hybridization probes.

14© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started
experimental design considerations

qPCR assays using an Eclipse probe employ two primers and a sequencespecific oligonucleotide probe, as illustrated in Figure 2.6. The probe iscomplementary to a sequence within the amplicon and contains a fluorescentreporter at the 3' end, a quencher at the 5' end, and a minor groove binder.
The unhybridized probe adopts a conformation that brings the reporter andquencher together, quenching the reporter. During the annealing step of PCR,
the probe hybridizes to the target with the help of the minor groove binder.
The probe thus becomes linearized, separating the reporter and quencher andallowing the reporter to fluoresce. The resulting fluorescent signal is proportional tothe amount of amplified product in the sample.

Q

R

5’

3’

In an intact Eclipse probe, the reporter isquenched when in close proximity to quencher

B
MG

Q
B
MG

R

During annealing, the probe unfolds and binds
to the target sequence to separate the reporterand quencher. The reporter fluoresces

R

Reporter

Q

Quencher

MGB

Minor groove binder

Fig. 2.6. Eclipse probes.

qPCR assays using Amplifluor chemistry employ two target-specific primers andone universal primer called the UniPrimer. The first target-specific primer contains
a 5' extension sequence called the Z-sequence that is also found at the 3' end of
the UniPrimer. As shown in Figure 2.7, the UniPrimer forms a hairpin structure.
A fluorescent reporter and a quencher are attached at the 5' and the 3' ends of thestem structure, respectively. In the hairpin conformation, the reporter fluorescenceis quenched due to its proximity to the quencher. During the first amplification cycle,
the first target-specific primer (with the Z-sequence) hybridizes to the templateand is extended. During the second amplification cycle, the second target-specificprimer is used to synthesize a new target template that contains a sequence
complementary to the Z-sequence. The product from the second amplification
cycle can then serve as the template for the UniPrimer. In the third amplification
cycle, the extended UniPrimer serves as a template for the next amplification cycle.
In the fourth cycle, extension of the template through the hairpin region of the
UniPrimer causes the UniPrimer to open up and adopt a linear configuration,© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

15

getting started
experimental design considerations

5’

3’

The Z primer anneals, and is extended in
the first amplification round

Z

Z

Q

R

Q

The UniPrimer anneals to the sequenceof the Z primer and is extended by thepolymerase

The UniPrimer-containing product serves
as a template for the other primer

Extension of primer causes the hairpin to
unfold and to separate the reporter andquencher. The reporter fluoresces

R

Q

R

R

Reporter

Q

QuencherFig. 2.7. Amplifluor primer.

which allows the reporter to fluoresce. Exponential amplification using the second
target-specific primer and the UniPrimer occurs in subsequent amplification cycles.
The resulting fluorescent signal is proportional to the amount of amplified product inthe sample.
Scorpions primer assays employ two primers, one of which serves as a probe
and contains a stem-loop structure with a 5' fluorescent reporter and 3' quencher,as illustrated in Figure 2.8. The loop sequence of the Scorpions probe iscomplementary to an internal portion of the target sequence on the same strand.
During the first amplification cycle, the Scorpions primer is extended and thesequence complementary to the loop sequence is generated on the same strand.
The Scorpions probe contains a PCR blocker just 3' of the quencher to prevent
read-through during the extension of the opposite strand. After subsequent
denaturation and annealing, the loop of the Scorpions probe hybridizes to thetarget sequence by an intramolecular interaction, and the reporter is separated
from the quencher. The resulting fluorescent signal is proportional to the amountof amplified product in the sample.
LUX primer assays employ two primers, one of which is a hairpin-shaped primer
with a fluorescent reporter attached near the 3' end, as illustrated in Figure 2.9.
In the intact primer, the reporter is quenched by the secondary structure of thehairpin. During amplification, the LUX primer is incorporated into the product andthe reporter fluoresces.
16© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started
experimental design considerations

R

R

Q

Q

The Scorpions primer acts as a probe.
The intact primer forms a hairpin so that thequenched reporter does not fluoresce

During annealing, the hairpin primer binds
to the template, and is then extendedR
Q

During subsequent denaturation, the reporter
separates from the quencher, and the loop
sequence binds to the internal target sequence.
The reporter on the extended Scorpions primer
fluoresces
R
Q

Reporter
Quencher
PCR blocker

Fig. 2.8. Scorpions primer.

R

The LUX primer forms a hairpin so that thequenched reporter does not fluoresce
Denaturation
R

The primer becomes single-stranded
Annealing
R

Extension
R

During extension, the primer is extended, andthe reporter fluoresces in the double-stranded
DNA product

R

ReporterFig. 2.9. LUX primers.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

17

getting started
experimental design considerations

The zymogene primer encodes thecatalytic DNA. During annealing, thezymogene primer anneals to the target
Extension
During extension, the catalytic
DNA is madeDenaturation
Annealing of probe
R

Q

During the next annealing step, thecatalytic DNA binds the probe andcleaves the reporter from the quencher

R

Q

The free reporter fluoresces
R

Reporter

Q

QuencherFig. 2.10. BD QZyme primers.

qPCR assays using BD QZyme primers employ a target-specific zymogene
primer, a target-specific reverse primer, and a universal oligonucleotide substrate as
shown in Figure 2.10. The oligonucleotide contains a fluorescent reporter on the
5' end and a quencher on the 3' end. When oligonucleotide substrate is intact, thefluorescence of the reporter is quenched by the quencher due to their proximity.
The zymogene primer contains a sequence that encodes a catalytic DNA. During
the first amplification cycle, the zymogene primer is extended. In the second cycle,
the product of the first cycle is used as the template by the target-specific reverse
primer, which is extended to create a new target sequence containing a catalytic
DNA region. In the subsequent annealing step, the fluorescently labeledoligonucleotide substrate hybridizes to the catalytic DNA sequence and is cleaved.
This cleavage separates the reporter from the quencher, resulting in a fluorescentsignal that is proportional to the amount of amplified product in the sample.

18© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started
design and optimization of SYBR Green I reactions

2.3 Design and Optimization of
SYBR Green I ReactionsA SYBR Green I assay uses a pair of PCR primers that amplifies a specific region
within the target sequence of interest and includes SYBR Green 1 for detecting theamplified product. The steps for developing a SYBR Green I assay are:
• Primer design and amplicon design• Assay validation and optimization
Sections 2.3.1 and 2.3.2 provide guidelines on how to carry out these two steps.

2.3.1 Primer and Amplicon Design
A successful real-time PCR reaction requires efficient and specific amplification of
the product. Both primers and target sequence can affect this efficiency. Therefore,care must be taken when choosing a target sequence and designing primers. A
number of free and commercially available software programs are available for thispurpose. One popular web-based program for primer design is Primer3
http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). A commerciallyavailable program such as Beacon Designer software performs both primer design
and amplicon selection.
For amplicon design, follow these guidelines:• Design amplicon to be 75–200 bp. Shorter amplicons are typically amplified withhigher efficiency. An amplicon should be at least 75 bp to easily distinguish itfrom any primer-dimers that might form
• Avoid secondary structure if possible. Use programs such as mfold
http://www.bioinfo.rpi.edu/applications/mfold/) to predict whether anamplicon will form any secondary structure at annealing temperature. See RealTime PCR: General Considerations (Bio-Rad bulletin 2593) for more details• Avoid templates with long (>4) repeats of single bases• Maintain a GC content of 50–60%
For primer design, follow these parameters:• Design primers with a GC content of 50–60%• Maintain a melting temperature (Tm) between 50ºC and 65ºC. We calculate Tmvalues using the nearest-neighbor method with values of 50 mM for salt
concentration and 300 nM for oligonucleotide concentration• Avoid secondary structure; adjust primer locations outside of the target sequence
secondary structure if required© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

19

getting started
design and optimization of SYBR Green I reactions• Avoid repeats of Gs or Cs longer than three bases• Place Gs and Cs on ends of primers• Check sequence of forward and reverse primers to ensure no 3' complementarity(avoid primer-dimer formation)• Verify specificity using tools such as the Basic Local Alignment Search Tool
(http://www.ncbi.nlm.nih.gov/blast/)

2.3.2 Assay Validation and OptimizationA SYBR Green I qPCR reaction contains the following components:• PCR master mix with SYBR Green I• Template• Primers
Preformulated real-time PCR master mixes containing buffer, DNA polymerase,dNTPs, and SYBR Green I dye are available from several vendors. We recommend
iQ™ SYBR® Green supermix.
Optimized SYBR Green I qPCR reactions should be sensitive and specific andshould exhibit good amplification efficiency over a broad dynamic range. To
determine the performance of your SYBR Green I qPCR assay, perform thefollowing two steps:• Identify the optimal annealing temperature for your assay• Construct a standard curve to evaluate assay performance

2.3.2.1 Annealing Temperature Optimization
The optimal annealing temperature can easily be assessed on qPCR instrumentsthat have a temperature gradient feature, such as the MiniOpticon™, MyiQ™,
DNA Engine Opticon®, Opticon™ 2, iCycler iQ®, Chromo4™, and iQ™5 systems.
A gradient feature allows you to test a range of annealing temperatures
simultaneously, so optimization reactions can be performed in a single experiment.
To find the optimal annealing temperature for your reaction, we recommend testinga range of annealing temperatures above and below the calculated Tm of the primers.
A sample annealing temperature optimization experiment is shown in Figure 2.11.
Because SYBR Green I binds to all dsDNA, it is necessary to check the specificity
of your qPCR assay by analyzing the reaction product(s). To do this, use the meltcurve function on your real-time instrument and also run products on an agarosegel. Figure 2.12 shows the melt-curve and agarose gel analyses from the annealing
temperature optimization experiment shown in Figure 2.11. The reaction withannealing temperature at 62.2°C is shown. An optimized SYBR Green I qPCR
reaction should have a single peak in the melt curve, corresponding to the single
band on the agarose gel, as shown in Figure 2.12.

20© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started

Fluorescencedesign and optimization of SYBR Green I reactions

62.2°C0.25

55.0°C
69.4°C

72.0°C

0
0

10

20

30

40

Cycle

Fig. 2.11. Annealing temperature optimization. An annealing temperature gradient of 55°C to 72°C was
performed on the Chromo4 system. The 62.2°C reaction gave the lowest CT value and was selected as the
optimal annealing temperature for this assay.

Nonspecific products that may have been coamplified with the specific productcan be identified by melt-curve analysis (Figure 2.13). In this example, the specificproduct is the peak with a Tm of 89°C and corresponds to the upper band on thegel. The nonspecific product is the peak with a Tm of 78°C and corresponds to thelower band in the gel. By comparing the gel image with the melt curve, you canidentify peaks in the melt curve that correspond to specific product, additional
nonspecific bands, and primer-dimers. If nonspecific products such as primerdimers are detected by melt-curve analysis, we recommend that you redesign
your primers (see Section 2.3.1).
B

1

2

Fluorescence

A

60

70

80

90

Temperature

Fig. 2.12. Validation of SYBR Green I reactions. A, melt-curve analysis, with the first derivative of thechange in fluorescence intensity as a function temperature plotted, and B, agarose gel analysis of thereaction products. Lane 1, molecular weight markers, 100–1,000 bp in 100 bp increments, 1,200 and
1,500 bp; lane 2, single PCR product corresponding to peak observed in (A).

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

21

getting started
design and optimization of SYBR Green I reactions

A

B

Fig. 2.13. Melt-curve analysis. The presence of a nonspecific product, in this case primer-dimers,
shows up as an additional peak in the melt-curve analysis. A, The negative first derivative of the change influorescence is plotted as a function of temperature. B, Gel analysis of the qPCR products. Lane 1,
AmpliSize 50–2,000 bp molecular ruler; lanes 2 and 3, two replicates from the reaction shown in (A).

2.3.2.2 Assay Performance Evaluation Using Standard Curves
The efficiency, reproducibility, and dynamic range of a SYBR Green I assay can be
determined by constructing a standard curve using serial dilutions of a known
template, as described in Section 1.1.3. The efficiency of the assay should be
90–105%, the R2 of the standard curve should be >0.980 or r > |–0.990|, and theCT values of the replicates should be similar.
It is important to note that the range of template concentrations used for the
standard curve must encompass the entire range of template concentration of
the test samples to show that results from the test samples are within the linear
dynamic range of the assay. If the test samples give results outside of the range ofthe standard curves, one of the following must be performed:• Construct a wider standard curve covering the test sample concentrations andperform analysis to ensure that the assay is linear in that new range• If the test samples give a lower CT than the highest concentration of standards
used in the standard curve, repeat the assay using diluted test samples• If the test samples give a higher CT than the lowest concentration of standards
used in the standard curve, repeat the assay using larger amounts of thetest samples

22© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started
design and optimization of TaqMan probe reactions

2.4 Design and Optimization of TaqMan
Probe Reactions
A TaqMan assay uses a pair of PCR primers and a dual-labeled target-specificfluorescent probe. The steps for developing a TaqMan assay are:
• Primer and probe design• Assay validation and optimization
Sections 2.4.1 and 2.4.2 provide guidelines on how to carry out these two steps.

2.4.1 Primer and Probe Design
As with any qPCR reaction, TaqMan-based assays require efficient and specificamplification of the product. Primer design rules are similar to those described in
Section 2.3.1. Typically, the primers are designed to have an annealing temperature
between 55 and 60ºC. We recommend using software such as Beacon Designer
for designing your TaqMan primers and TaqMan probe. Because the dual-labeledprobe is the most costly component of a TaqMan assay, we suggest that you orderthe two primers and validate their performance using SYBR Green I before ordering
the dual-labeled probe. See Section 2.3 for details on how to validate a primer set
in a SYBR Green I reaction.
The TaqMan probe should have a Tm 5–10°C higher than that of the primers.
In most cases, the probe should be <30 nucleotides and must not contain a G at
its 5' end because this could quench the fluorescent signal even after hydrolysis.
Choose a sequence within the target that has a GC content of 30–80%, anddesign the probe to anneal to the strand that has more Gs than Cs (so the probe
contains more Cs than Gs).
An important aspect of designing a TaqMan probe is reporter and quencher
selection. A list of commonly used combinations of reporters and quenchers
is shown in Table 2.1. We recommend using FAM-labeled probes when designingsingleplex reactions, because they are inexpensive and readily available, perform
well, and can be detected by all instruments currently on the market.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

23

getting started
design and optimization of TaqMan probe reactions

Table 2.1. Commonly used combinations of reporters and quenchers.
ReporterCompatible Quencher

FAM
TET
HEX
TAMRA
Texas Red
ROX
Cy5

BHQ1, DABCYL,* TAMRA**
BHQ1, DABCYL*
BHQ1, BHQ2, DABCYL*
BHQ2, DABCYL*
BHQ2, BHQ3, DABCYL*
BHQ2, BHQ3, DABCYL*
BHQ2, BHQ3

* DABCYL is a mechanical quencher only appropriate for molecular beacons.
** TAMRA is not recommended as a quencher, but will work for single-color FAM assays. TAMRA will notwork well as a quencher on molecular beacons.

Another important consideration for obtaining accurate real-time qPCR data isprobe quality. Even a perfectly designed probe can fail if the probe is improperly
synthesized or purified. Improper removal of uncoupled fluorescent label, inefficient
coupling, and/or poor quenching can produce high fluorescent background ornoise. A low signal-to-noise ratio results in decreased sensitivity and a smaller
linear dynamic range. Two probes with identical sequences and identical
fluorophore labels can be measurably different when synthesized by different
suppliers or even at different times by the same supplier. We recommend saving
aliquots of each probe for direct comparisons with newly synthesized probes.

2.4.2 Assay Validation and Optimization
A TaqMan probe-based qPCR reaction contains the following components:• PCR master mix• Template• Primers• Probe(s)Preformulated PCR master mixes containing buffer, DNA polymerase, anddNTPs are commercially available from several vendors. For TaqMan assays,
we recommend using iQ™ supermix with 300 nM of each of the two primers and
200 nM of probe(s).
TaqMan assays require careful attention to temperature conditions. A typical
TaqMan protocol contains a denaturation step followed by a combined annealing
and extension step at 55–60°C, instead of the traditional three-step PCR cycle ofdenaturation, annealing, and extension. This is to ensure that the probe remains
bound to its target during primer extension. Typical TaqMan probes for nucleic acidquantification are designed to have a Tm of 60–70°C.

24© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

getting started
design and optimization of TaqMan probe reactions

An optimized TaqMan assay should be sensitive and specific, and should exhibit
good amplification efficiency over a broad dynamic range. To determine theperformance of your TaqMan assay, use the procedure outlined in Sections 1.1.3
and 2.3.2. In short, construct a standard curve using dilutions of a known template
and use this curve to determine the efficiency of the assay along with R2 or r of theregression line. The efficiency of the reaction should be between 90 and 105%,
the R2 should be >0.980 or r > |–0.990|, and the replicates should give similar
CT values.
If the assay performs within these specifications, you are ready to start yourexperiment. If the assay performs outside these specifications, we suggest that you
redesign your primers and TaqMan probe.
It is important to note that the range of template concentrations used for the
standard curve must encompass the entire range of template concentrations of
the test samples to demonstrate that results from the test samples are within the
dynamic range of the assay. If test samples give results outside the range of thestandard curve, one of the three following steps must be performed:• Construct a wider standard curve covering the test sample concentrations andperform analysis to ensure that the assay is linear in that new range• If the test samples give a lower CT than the highest concentration of standards
used in the standard curve, repeat the assay using diluted test samples• If the test samples give a higher CT than the lowest concentration of standards
used in the standard curve, repeat the assay using larger amounts of thetest samples© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

25

26

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

Multiplexing
Considerations
Primer and Probe Design for Multiplexing

28

Selection of Reporters and Quenchers for Multiplexing

29

Optimization of Individual Assays Before Multiplexing

29

Validation of Multiplex Assays

29

Optimization of Multiplex Assays

30multiplexing considerations
primer and probe design for multiplexing

3. Multiplexing Considerations
If you have decided to perform your qPCR experiments by amplifying more than
one target in a single reaction tube, that is, multiplexing (see Section 2.2.1),
read the following section before beginning your experiments.
Successful multiplexing results from careful experimental design and optimizationof reaction conditions, not from simply combining all primers and templates in thesame tube. This is because amplification of any one target can influence theamplification of the other targets in the same tube.
A common challenge for multiplex real-time PCR is amplifying targets that havesignificantly different concentrations. An example comes from gene expression
studies in which a gene of interest (GOI) is compared to a reference gene. If thereference gene is present at great excess and has a higher amplification efficiency
than the GOI, the amplification of the GOI may be outcompeted and thus
compromised by amplification of the reference gene when both are amplified in
the same tube (multiplexed). This would result in an underestimation of the amountof GOI present in the sample.
The following steps should be used to develop a multiplex assay:• Design primer and probe sequences• Select reporters and quenchers for probes• Optimize individual assays• Validate the multiplex assay• Optimize the multiplex assay, if necessary
In the following sections, we discuss each of these steps in detail.

3.1 Primer and Probe Designfor Multiplexing
If you are setting up a multiplex TaqMan assay, follow the guidelines in Section 2.4
to design the individual TaqMan assays. Design all primers with approximately thesame Tm (55–60°C), and all probes with approximately the same Tm (~5–10°C
higher than the primers). It is important to make sure that the different primer andprobe sets do not exhibit complementarity to one another because all primers andprobes will be present in one reaction. We recommend the use of commerciallyavailable software such as Beacon Designer to simplify the design of primer andprobe sets for multiplex reactions.

28© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidemultiplexing considerations
selection of reporters and quenchers for multiplexing

3.2 Selection of Reporters andQuenchers for Multiplexing
Multiplex reactions require the use of multiple reporters to follow each individual
amplification reaction. To distinguish each reaction, choose reporter fluorophores
with minimally overlapping emission spectra. The selected fluorophores alsoneed to be compatible with the excitation and emission filters of your real-time
instrument. See your instrument manual for a list of compatible fluorophores.
For example, for a fourplex reaction on the Chromo4™, iCycler iQ®, and iQ™5
instruments, we recommend using FAM, HEX, Texas Red, and Cy5. For a fiveplex
assay on the iQ5 system, we recommend using FAM, HEX, TAMRA, Texas Red,
and Cy5.

3.3 Optimization of Individual Assays
Before Multiplexing
The first step in assembling a multiplex assay is to optimize the individual reactions.
Determine the efficiency of each individual reaction by constructing a standard
curve using a series of template dilutions as described in Sections 1.1.3 and 2.3.2.
The efficiency of the individual reactions should be 90–105%.

3.4 Validation of Multiplex Assays
Run singleplex and multiplex assays for your targets on the same plate andcompare the CT values. The values obtained for a given target in the singleplex andmultiplex assays should not be significantly different. If the CT values from thesingleplex and the multiplex reaction are significantly different, you will need to
optimize your reactions. This can be achieved by varying the concentration ofreaction components as described in Section 3.5.
iQ™ multiplex powermix greatly simplifies optimization of multiplex assays, routinely
yielding similar efficiencies in singleplex and multiplex assays.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

29

multiplexing considerations
optimization of multiplex assays

3.5 Optimization of Multiplex Assays
If a multiplex reaction is not optimized, the amplification of the less-efficient or lessabundant target can be inhibited by the more-efficient or more-abundant target.
This is because reaction components, such as DNA polymerase and nucleotides,
become limiting in later cycles and the amplification of the less-efficient or lessabundant target is compromised.
This inhibitory effect is apparent when comparing the amplification plot of a fixedamount of amplicon in a singleplex reaction to that of the same amplicon in a
multiplex reaction: the CT for the multiplex reaction is delayed compared to the CT
for the singleplex reaction. This is demonstrated in Figure 3.1, where amplificationof four targets, β-actin, ornithine decarboxylase (ODC), ODC antizyme (OAZ), andantizyme inhibitor (AZI), was carried out in singleplex reactions (dark blue line) andin a multiplex reaction with otherwise identical reaction components (light blue line).
Amplification of the two less-abundant targets, ODC and AZI, was affected,
and resulted in delayed CT values in the multiplex reactions compared to thecorresponding singleplex reactions.
10,000β-Actin

1,000— Singleplex, 1.25 U iTaq
— Fourplex, 1.25 U iTaq
1,000 — Fourplex, 2.5 U iTaq
— Fourplex, 3.75 U iTaq
— Fourplex, 5 U iTaq

ODC

100

PCR baseline subtracted RFU

100
10
10
1
10,000

0

4

8

12

16 20

24

28 32

36 40

AZI

1
10,000

1,000

1,000

100

100

10

10

1

0

4

8

12

16 20 24
Cycle

28 32

36 40

0

4

8

12

16 20

24

28 32

36 40

8

12

16 20

24

28 32

36 40

OAZ

1
0

4

Cycle

Fig. 3.1. Optimization of iTaq™ DNA polymerase concentration in fourplex reactions. MgCl2 and dNTP
concentrations were kept constant while the singleplex iTaq concentration (1x) was compared to multiplex
conditions using increasing amounts of iTaq DNA polymerase (1–4x). The β-actin and OAZ genes (thosewith the highest expression in this example) were amplified with similar efficiency in singleplex and multiplex
conditions at all iTaq concentrations tested. The genes with lower expression, AZI and ODC, required
additional iTaq polymerase to attain multiplex amplification efficiencies comparable to those of thesingleplex amplification.

30© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidemultiplexing considerations
optimization of multiplex assays

One method for optimizing multiplex reactions is to increase the concentrations of
DNA polymerase, dNTPs, and MgCl2. To optimize the amplification of β-actin,
ODC, AZI, and OAZ in the multiplex reaction, we sequentially increased theconcentrations of DNA polymerase, MgCl2, and dNTPs.
First, we increased the concentration of the iTaq DNA polymerase in the multiplex
reaction, in 1.25 unit (U) increments, from 1.25 U per reaction to 5 U per reaction.
With increased concentrations of DNA polymerase, we observed increased
amplification efficiencies for ODC and AZI, as shown in Figure 3.1. Based on these
data, we chose to use 3.75 U DNA polymerase in the subsequent optimization steps.
Next we tested the effect of increasing MgCl2 from 3.5 mM to 5 mM, and dNTPs
from 200 µM to 400 µM. As shown in Figure 3.2, when the iTaq DNA polymerase
concentration was set at 3.75 U per 50 µl reaction, our four-gene multiplex assay
benefited from 5 mM MgCl2, with no increase necessary for dNTPs.
10,000β-Actin

10,000

PCR baseline subtracted RFU

MgCI2
dNTP
— 3.5 mM 200 µM
1,000 — 3.5 mM 400 µM— 5.0 mM 200 µM— 5.0 mM 400 µM

1,000

100

100

10

10

1

1,000

0

4

8

12

16

20 24

28

32 36

40

AZI

1

1,000

100

100

10

10

1

0

4

8

12

16

ODC

20 24
Cycle

28

32 36

40

1

0

4

8

12

16

8

12

16

20 24

28

32 36

40

20 24

28

32 36

40

OAZ

0

4

Cycle

Fig. 3.2. Optimization of MgCl2 and dNTP concentrations in fourplex reactions. While keeping the
iTaq DNA polymerase concentration constant at 3.75 U per 50 µl reaction, the effects of MgCl2 and dNTPs
concentration were assessed. The combination of 5.0 mM MgCl2, 200 µM dNTPs, and 3.75 U iTaq DNA
polymerase gave the best amplification in multiplex reactions (no singleplex reactions are shown here).

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide31

multiplexing considerations
optimization of multiplex assays

To verify the performance of the optimized multiplex assay, we performed side-byside comparisons of single- and multiplex reactions for each primer-probe set atthe optimized condition (3.75 U iTaq, 5 mM MgCl2, 200 µM dNTPs). The real-time
amplification plots generated using singleplex and multiplex conditions should
show the same CT values and be superimposable during the exponential phaseof the amplification. Successful multiplex conditions were indeed achieved whenusing total RNA samples from human prostate (Figure 3.3) and small intestine(data not shown) as template.

PCR baseline subtracted RFU

10,000β-Actin

10,000

1,000

1,000

100

100

10

10

1

1,000

0

4

8

12

16

20 24

28

32 36

1

40

AZI

10,000

ODC

0

4

8

12

16

20 24

28

32 36

40

8

12

16

20 24
Cycle

28

32 36

40

OAZ

1,000
100
100
10
10
1

0

4

8

12

16

20 24
Cycle

28

32 36

40

1

0

4

CT Values
Singleplex
Multiplex

β-Actin17.0 ± 0.0
17.3 ± 0.0

ODC23.0 ± 0.2
23.1 ± 0.2

AZI22.2 ± 0.1
22.2 ± 0.1

OAZ20.8 ± 0.1
20.8 ± 0.2

Fig. 3.3. Verification of multiplex assay performance. Data from singleplex (blue) and fourplex (red)reactions (four replicates, each using human prostate cDNA as template) are superimposed. The plots
overlap completely during the exponential phase. The table shows the average CT values for the singleplex
and multiplex reactions.

32© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

Real-Time qPCR
Data Analysis
Absolute Quantification

35

When Should Absolute Quantification Be Used?

35

Absolute Quantification Using a Standard Curve

35

Relative Quantification

37

When Should Relative Quantification Be Used?

37

Relative Quantification Normalized Against Unit Mass

38

Relative Quantification Normalized to a Reference Gene40

The 2–∆∆CT (Livak) Method

41

The ∆CT Method Using a Reference Gene42

The Pfaffl Method43real-time qPCR data analysis

4. Real-Time qPCR
Data Analysis
As discussed in Section 1, real-time qPCR is a method for determining the amountof nucleic acid in a sample. Knowing that you have 500,000 molecules of p53
mRNA in your sample tube, however, is not biologically meaningful; biologists are
typically more interested in statements such as: 1) the number of viral particles ina given amount of blood, or 2) the fold change of p53 mRNA in an “equivalentamount” of cancerous vs. normal tissue. The analysis methods that address these
two scenarios are commonly known as absolute quantification and relative
quantification, respectively.
Absolute quantification is achieved by comparing the CT values of the test
samples to a standard curve. The result of the analysis is quantity of nucleic acid(copy number, µg) per given amount of sample (per cell, per µg of total RNA). In
relative quantification, the analysis result is a ratio: the relative amount (folddifference) of a target nucleic acid for equivalent amounts of test and control
sample A vs. B. Both cases need to address the question of what the “amount ofsample” is, and in relative quantification, to ensure that equivalent amounts ofsamples are compared.
For both absolute and relative quantification methods, quantities obtained froma qPCR experiment must be normalized in such a way that the data become
biologically meaningful. This is done through the use of normalizers. In absolute
quantification, normalizers are used to adjust or standardize the obtained target
quantity to the unit amount of sample. In relative quantification, normalizers areused to ensure that the target quantities from equivalent amounts of samples arecompared. Although the normalizer for either quantification method can be thenumber of cells used for template preparation, µg of nucleic acid used as PCR
template, or the expression level of a reference gene, the first two are morecommonly used for absolute quantification, whereas the third is typically used for
relative quantification. A reference gene is one whose expression level is constantacross all test samples and whose expression is not affected by the experimental
treatment under study. The use of a reference gene is advantageous in cases
where the precise quantification of input RNA amount is not possible, such as incases where only a small amount of starting template is available.

34© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidereal-time qPCR data analysis
absolute quantification

Many different methods are available for performing both absolute and relative
quantification. In the next few sections, we provide examples and guidelines
on when and how to use absolute vs. relative quantification methods, andfurther explore the concept of normalizer as applied to each of the twoquantification strategies.

4.1 Absolute Quantification
4.1.1 When Should Absolute Quantification Be Used?
Let’s start by examining a sample case that calls for absolute quantification.
A doctor is interested in determining the number of viral particles per ml of bloodfrom a patient. To do so, the doctor extracts DNA from 10 ml of blood anddetermines the number of viral particles by running a real-time PCR assay specificto the viral DNA. By comparing the CT value obtained for the test sample to a
standard curve of known amounts of viral particles, the doctor can interpolatethat there are 10,000 viral particles in the assayed DNA sample. Based on thisinformation, she is then able to determine that there are 1,000 viral particles/mlof blood.
In the above example, absolute quantification was chosen because the doctor wasinterested in the quantity of nucleic acid (number of viral particles) per given amountof sample (ml of blood). Thus, the normalizer is “ml of blood” in this example.
The end result is a quantitative description of a single sample, which does notdepend on the properties of any other sample. In other words, use the absolute
quantification method when you are interested in finding out an intrinsic property
of a given sample.

4.1.2 Absolute Quantification Using a Standard Curve
In absolute quantification, the quantity (e.g., copy number or unit mass) of theunknown sample is interpolated from a range of standards of known quantity.
To construct a standard curve, a template with known concentration is required.
Dilution of this template is then performed and these dilutions serve as thestandards. The unknown test samples are assayed with the standards in thesame experimental run. The standard curve constructed from the diluted standard
template can then be used to determine the target quantity in the unknown sample
by interpolation, similarly to using molecular size standards to determine themolecular size of an unknown DNA band on an agarose gel.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide35

real-time qPCR data analysis
absolute quantification

An example of using a standard curve to determine the copy number of a particulartarget nucleic acid is shown in Figure 4.1. In this example, we were interested indetermining the copy number of the β-actin gene in two samples, A and B.
A 10-fold dilution series was created from a sample with a known concentrationof β-actin, resulting in a set of standards containing 102–107 copies of template.
The standards and the samples were then assayed in the same run.
y = –3.50x + 37.20; r2 = 0.999

30

25

CT

Sample B
Sample A

20

15

2

3

4

5

6

7

log Quantity
Fig. 4.1. An example of absolute quantification using a standard curve. To determine the copy numberof β-actin in unknown samples A and B, 10-fold dilutions of a known concentration of template (102–107
copies β-actin) were assayed with the two unknown samples in the same run using a SYBR Green I assay
specific to β-actin. The regression line from the dilution curve was used to determine the copy number ofthe unknown samples. All standard dilutions and unknown samples were assayed in triplicate on the
Chromo4 real-time PCR detection system.

A standard curve was constructed, with the logarithm of the initial copy number ofthe standards plotted along the x-axis and their respective CT values plotted along
the y-axis (Figure 4.1). The equation for the linear regression line [y = mx + b, or
CT = m(log quantity) + b] is shown on the top of the graph.
Based on the equation for the linear regression, we can derive the following
equation to determine the quantity of an unknown sample:
n–b
Nn = 10( m ), where n = CT
CT – b

Quantity = 10( m )36© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidereal-time qPCR data analysis
relative quantification

Table 4.1. Determination of the absolute copy number of β-actin in unknown
samples A and B using the absolute quantification method. The equation of
the linear regression line shown in Figure 4.1 was used to calculate the copy
number of the unknown samples.
SampleA
A
A

ReplicateCT

Copies

1
2
3

18.61
18.41
18.87

204,577
234,115
172,300

1
2
3

17.06
17.07
17.00

203,664 ± 30,917

Average
B
B
B
Average569,789
563,823591,173
574,928 ± 14,381

The copy numbers of the individual replicate assays for samples A and B were
determined using their CT values in the above equation. Typically, when replicatesare sampled, a mean and standard deviation of the individual samples is reported,as shown in the last column of Table 4.1. It is important to note that the standard
curve may only be used to interpolate, not extrapolate, the quantity of the unknown
sample. This is because the assay may not be linear outside the range covered by
the standards tested.
Common real-time PCR applications that employ absolute quantification include
chromosome or gene copy number determination and viral load determination.
This method of quantification is conceptually simple and the mathematics of theanalysis is easy to perform. The method does, however, require a reliable source oftemplate of known concentration, and standards must be amplified in parallel withthe samples every time the experiment is performed.

4.2 Relative Quantification
4.2.1 When Should Relative Quantification Be Used?
Now let’s examine a sample case that calls for relative quantification. A researcher
wants to know whether the expression level of p53 differs between cancerous andnormal ovarian cells, and if so, by how much. He wants to find out the relative
amount, sometimes called the “fold difference”, of p53 mRNA in equivalentamounts of the two tissues. The researcher can choose one of the following
experimental designs depending on the type of normalizer he wishes to employ:(1) The researcher extracts RNA from 1,000 cancerous and 1,000 normal ovariancells, and determines the amount of p53 mRNA in the samples by running areverse transcription (RT) qPCR assay specific for p53 mRNA. The researcher thenfinds out the relative fold difference of p53 mRNA by taking the ratio of the numberof p53 mRNA molecules in RNA samples from the equivalent number of cancerous
and normal ovarian cells.
© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide37

real-time qPCR data analysis
relative quantification(2) If the researcher had previously determined that the level of GAPDH mRNA
expression is identical in cancerous and normal cells, the researcher can extract
RNA from an approximately equivalent number of cancerous and normal ovariancells without determining the exact number of cells. The level of p53 mRNA and
GAPDH mRNA in the samples were then determined by a RT-qPCR assay. The
relative expression of p53 in cancerous vs. normal cells was determined by taking
the ratio of the GAPDH-normalized p53 expression in the two different cell types.
In the above example, relative quantification was chosen because the researcher
was interested in the relative amount of a target nucleic acid in equivalent amountsof samples A and B. The difference between the two analysis methods describedabove is the type of normalizer used. In the first scenario, the normalizer is thenumber of cells. In the second scenario, the normalizer is the GAPDH mRNA
expression level, which was previously determined to be constant between thetwo cell types. The mathematical manipulations for the two scenarios arepresented in Sections 4.2.2 and 4.2.3, respectively. In both cases, the end result
is a quantitative description of some property of one sample relative to the same
property of another sample. In other words, use relative quantification to comparea specific property between multiple samples.

4.2.2 Relative Quantification Normalized Against
Unit Mass
The advantages of using a unit mass (such as cell number or µg of nucleic acid)rather than a reference gene as the normalizer are that the experimental design
is conceptually simple and the mathematical treatment is straightforward.
The method requires accurate quantification of the starting material, regardlessof whether cell number or µg of nucleic acid is used as the normalizer.
When comparing multiple samples using relative quantification, one sample isusually chosen as the calibrator (sometimes known as the control sample),and the expression of the target gene in all other samples is expressed as anincrease or decrease relative to the calibrator. Customarily, the untreated orbaseline sample is chosen as the calibrator. In the case of the p53 example,
we may choose the normal ovarian cells as the calibrator and the cancerous
ovarian cells as the test sample.

38© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidereal-time qPCR data analysis
relative quantification

To determine the relative expression of p53 in cancerous vs. normal ovariancells, total RNA was prepared from an equal number of normal ovarian cells andcancerous ovarian cells. The CT values for the test sample (cancerous cells) and thecalibrator sample (normal cells) were then used to calculate the ratio between thetwo by the following equation:
Ratio(test/calibrator) = ECT(calibrator) – CT(test)
E is the efficiency of the reaction and can be determined as described in Section
1.1.3. If we assume that the assay has perfect amplification efficiency (that is, thetemplate is doubled in each amplification cycle), then the equation above becomes:
Ratio(test/calibrator) = 2CT(calibrator) – CT(test)
or
Ratio(test/calibrator) = 2∆CT
where ∆CT = CT(calibrator) – CT(test)
This method for calculating relative expression is often referred to as the ∆CTmethod. A hypothetical example is given below to demonstrate how the ∆CTmethod can be used to determine relative expression of a target gene (p53) incancerous and normal ovarian cells.
Example: cDNA representing 50 ng of total RNA isolated from both normal andtumor ovarian cells was assayed for p53 message. The CT values for each sample
are shown below:
SampleCT for p53 (target)

Normal (calibrator)
Tumor (test)

15.0
12.0

Assuming 100% amplification efficiency (E = 2), and choosing the normal cells as
the calibrator, the relative expression of p53 expression in cancerous vs. normal
ovarian cells is calculated as follows:
Ratio(test/calibrator) = 2CT(calibrator) – CT(test)= 2(15 – 12)=8
Therefore, the expression of p53 is 8-fold higher in tumor cells than in normal
ovarian cells.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

39

real-time qPCR data analysis
relative quantification

4.2.3 Relative Quantification Normalized to a
Reference Gene
The advantage of using a reference gene (such as GAPDH, β-actin, etc.) rather
than unit mass as a normalizer is that this method circumvents the need for
accurate quantification and loading of the starting material. This is especiallyconvenient when performing relative gene expression experiments where starting
material is frequently limited. The drawback is that this method requires theavailability of a known reference gene or genes with constant expression in all
samples tested and whose expression is not changed by the treatment understudy. The identification of such a reference gene is not trivial, and recently it has
been proposed that in most cases, the use of multiple reference genes may benecessary for accurate quantification (see Vandesompele et al., Genome Biology 3,
research 0034.1–0034.11, 2002, for detailed discussion).
As discussed in the previous section, when comparing multiple samples using
relative quantification, one of the samples is usually chosen as the calibrator,
and the expression of the target gene in all other samples is expressed as anincrease or decrease relative to the calibrator. Customarily, the untreated orbaseline sample is chosen as the calibrator. In the case of the p53 example,
we may choose the normal ovarian cells as the calibrator and the cancerous
ovarian cells as the test sample. To determine the relative expression of a target
gene in the test sample and calibrator sample using reference gene(s) as thenormalizer, the expression levels of both the target and the reference genes need
to be determined using RT-qPCR. In short, you need to determine the CT values,
as shown in Table 4.2.
Table 4.2. CT values required for relative quantification with reference geneas the normalizer.
Test

Calibrator (cal)Target geneCT(target, test)

CT(target, cal)

Reference geneCT(ref, test)

CT(ref, cal)After the CT values are measured, different methods can be used to determine
the expression level of the target gene in the test sample relative to the calibrator
sample. In the following sections, we present three methods for relative quantification
using a reference gene: 1) the Livak method, also known as the 2–∆∆CT method, 2)
the ∆CT method using a reference gene, and 3) the Pfaffl method. Each method
has advantages and disadvantages, as well as assumptions that must be satisfied
for the results of the analysis to be valid.

40© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

quantitative PCR data analysis
relative quantification

4.2.3.1 The 2–∆∆∆CT (Livak) Method
The 2–∆∆CT method for relative gene expression analysis is widely used and easy
to perform. This method assumes that both target and reference genes areamplified with efficiencies near 100% and within 5% of each other. Before using
the 2–∆∆CT method, it is essential to verify the assumptions by determining theamplification efficiencies of the target and the reference genes. The amplification
efficiency of the target and the reference gene can be determined by the method
outlined in Section 1.1.3.
Once you have established that the target and reference genes have similar andnearly 100% amplification efficiencies, you can determine the relative difference in
expression level of your target gene in different samples using the steps below:
First, normalize the CT of the target gene to that of the reference (ref) gene, for boththe test sample and the calibrator sample:∆CT(test) = CT(target, test) – CT(ref, test)∆CT(calibrator) = CT(target, calibrator) – CT(ref, calibrator)
Second, normalize the ∆CT of the test sample to the ∆CT of the calibrator:∆∆CT = ∆CT(test) – ∆CT(calibrator)
Finally, calculate the expression ratio:
2–∆∆CT = Normalized expression ratio
The result obtained is the fold increase (or decrease) of the target gene in the test
sample relative to the calibrator sample and is normalized to the expression ofa reference gene. Normalizing the expression of the target gene to that of thereference gene compensates for any difference in the amount of sample tissue.
If the target and the reference genes do not have similar amplification efficiencies
you can either optimize or redesign the assays, or you can use the Pfaffl method
described in Section 4.2.3.3. If, on the other hand, the target and the reference
genes have identical amplification efficiency, but the efficiency is not equal to 2,
a modified form of the 2–∆∆CT method may be used by replacing the 2 in theequation by the actual amplification efficiency. For example, if the amplification
efficiency of both the target and the reference gene is 1.95, the formula 1.95–∆∆CT
should be used.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide41

real-time qPCR data analysis
relative quantification

The following hypothetical example demonstrates how the 2–∆∆CT method is used todetermine relative expression of a target gene (p53) in cancerous and normal
ovarian cells.
Example: cDNAs representing 50 ng of total RNA isolated from both normal andtumor ovarian cells were assayed for p53 (target gene) and GAPDH (referencegene) message. GAPDH can serve as a reference gene for this study because
previous studies showed that GAPDH expression does not vary between normal
and tumor cells. The CT values for each sample are shown below:
SampleCT p53 (target)

CT GAPDH (reference)

Normal (calibrator)
Tumor (test)

15.0
12.0

16.5
15.9

To calculate relative expression using the steps described above, the CT of thetarget gene is normalized to the CT of the reference gene for both the test sample
and the calibrator sample:∆CT(normal) = 15.0 – 16.5 = –1.5
∆CT(tumor) = 12.0 – 15.9 = –3.9
Second, the ∆CT of the test sample is normalized to the ∆CT of the calibrator:∆∆CT = ∆CT(tumor) – ∆CT(normal)= –3.9 – (–1.5) = –2.4
Finally, the expression ratio is calculated:
2–∆∆CT = 2–(–2.4) = 5.3
Tumor cells are expressing p53 at a 5.3-fold higher level than normal cells.

4.2.3.2 The ∆CT Method Using a Reference GeneThe ∆CT method using a reference gene is a variation of the Livak method thatis simpler to perform and gives essentially the same results. In contrast to the∆CT values obtained in Section 4.2.2, this method uses the difference between
reference and target CT values for each sample. Despite the simplicity of theapproach, it is indeed normalized expression. The expression level of the reference
gene is taken into account. The key difference in the results is that the expression
value of the calibrator sample is not 1.0. If the resulting expression values
obtained in this method are divided by the expression value of a chosen calibrator,
the results of this calculation are exactly the same as those obtained with the
2–∆∆CT method:
Ratio (reference/target) = 2CT(reference) – CT(target)

42© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidereal-time qPCR data analysis
relative quantification

The mathematical assumptions for this approach are the same as those for the
2–∆∆CT method.
Example: cDNA representing 50 ng of total RNA isolated from both normal andtumor ovarian cells was assayed in triplicate for p53 and GAPDH message.
Previous studies have concluded that GAPDH is a good reference gene for thisstudy. The results are shown below:
SampleCT p53 (target)

CT GAPDH (reference)

Normal (calibrator)
Tumor (test)

15.0
12.0

16.5
15.9

To calculate relative expression, simply normalize p53 expression for each sample:2(CT(GAPDH) – CT(p53)) = Expression
For normal cells, this yields 2(16.5 – 15) = 2.8
For tumor cells, this yields 2(15.9 – 12) = 14.9
Although at first glance, these results appear quite different from those obtainedusing the 2–∆∆CT method, a quick evaluation of the ratio between the two samples
will reveal that these give precisely the same results:
Normal expression = Normal/Normal = 2.8/2.8 = 1
Tumor expression = Tumor/Normal = 14.9/2.8 = 5.3

4.2.3.3 The Pfaffl Method
The 2–∆∆CT method for calculating relative gene expression is only valid when
the amplification efficiencies of the target and reference genes are similar. If theamplification efficiencies of the two amplicons are not the same, an alternative
formula must be used to determine the relative expression of the target gene indifferent samples. To determine the expression ratio between the sample andcalibrator, use the following formula:

Ratio =

(Etarget)∆CT, target (calibrator – test)(Eref)∆CT, ref (calibrator – test)© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

43

quantitative PCR data analysis
relative quantification

In the above equation, Etarget and Eref are the amplification efficiencies of the target
and reference genes, respectively. ∆CT, target (calibrator – test) = CT of the target
gene in the calibrator minus the CT of the target gene in the test sample, and∆CT, ref (calibrator – test) is the CT of the reference gene in the calibrator minus
the CT of the reference gene in the test sample.
The above equation assumes that each gene (target and reference) has the same
amplification efficiency in test samples and calibrator samples, but it is not necessarythat the target and reference genes have the same amplification efficiency aseach other.
The 2–∆∆CT method and the Pfaffl method are very closely related; in fact, the 2–∆∆CT
method is simply a special case of the Pfaffl method where Etarget = Eref = 2. If wesubstitute Etarget and Eref with 2, then the Pfaffl method simplifies as follows:
2∆CT, target (calibrator – test)
Ratio = 2∆CT, ref (calibrator – test)= 2–[(CT, target (test) – CT, target (calibrator)] – [(CT, ref (test) – CT, ref (calibrator)]= 2–∆∆CT

44© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

Gene Expression
Analysis
Experimental Design

46

RNA Isolation

47

Sample Collection

47

RNA Extraction

48

Analyzing Nucleic Acid Quantity and Quality

48

cDNA Template Preparation (Reverse Transcription)

49

qPCR Assay Development

50

Experimentation

51

Reaction Components for Multiplex Assay

51

Cycling Protocol

51

Gene Expression Data Analysis

52gene expression analysis
experimental design

5. Gene Expression
Analysis
The most common application of real-time PCR is the study of gene expression.
Measuring gene expression is of fundamental importance in many areas ofcontemporary biomedical research, ranging from basic science to practicalapplications in industry and medicine. In most gene expression studies,
researchers are interested in determining the relative gene expression levels intest vs. control samples. For example, a researcher might be interested in theexpression of a particular gene in cancerous vs. normal tissue. In this section,
general guidelines and a sample gene expression experiment are presented todemonstrate how to perform gene expression analysis using real-time PCR.

5.1 Experimental Design
A sample gene expression analysis using a multiplex TaqMan assay is presented in
the following sections. In this example, we’re interested in the relative expressionof three genes in the polyamine biosynthesis pathway, ornithine decarboxylase(ODC), ODC antizyme (OAZ), and antizyme inhibitor (AZI), in two different samples,
sample A and sample B. Due to possible pipetting errors and initial quantification
errors of the input RNA, the amount of starting cDNA in the different real-timereactions may be different. In this example, the expression of a reference gene,
β-actin, was chosen as the normalizer to control for any difference in cDNA input
amount. The following steps were performed to determine the relative expression
level of ODC, OAZ, and AZI in the two different samples:
1. RNA was isolated from sample A and sample B.
2. RNA was reverse transcribed into cDNA.
3. The amount of the target genes (ODC, OAZ, and AZI) and the reference gene
(β-actin) was determined in each of the cDNA samples using a multiplex
qPCR assay.
4. Data were analyzed and the relative expression of each of the target genes in thetwo samples was calculated.

46© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegene expression analysis
rna isolation

This workflow, which is typical of RT-qPCR experiments, is summarized in
Figure 5.1. In the following sections, we will go over practical considerations of
performing each step shown in the gene expression analysis workflow.

RNA isolation

Reverse transcription (RT)qPCR assay development

qPCR experiment

Data analysis
Fig. 5.1. Gene expression analysis workflow.

5.2 RNA Isolation
5.2.1 Sample Collection
For quantifying gene expression, sample material should be as homogeneous
as possible. If your tissue sample consists of many different cell types, pinpointing
the expression pattern of your target gene may be difficult. If you have aheterogeneous sample, use one of the many methods that are available forseparating and isolating specific cell types. These methods include tissue
dissection, needle biopsies, and laser capture microdissection. The collected
cells can then be used to obtain the RNA samples.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

47

gene expression analysis
rna isolation

5.2.2 RNA Extraction
Either total or poly(A+) RNA can be used for most real-time RT-qPCR applications.
One critical consideration in working with RNA is to avoid RNases in your solutions,consumables, and labware. Ready-to-use solutions that are RNase-free can bepurchased. Alternatively, treat solutions with diethyl pyrocarbonate (DEPC), andthen autoclave them. RNases on labware can also be inactivated by DEPC
treatment, or by baking at 250°C for 3 hr. RNase-free consumables are available
for purchase from many commercial sources.
Prepared RNA samples may need DNase treatment to prevent potential
amplification of any contaminating genomic DNA, which could lead tooverestimation of the copy number of an mRNA. When starting material islimited, however, DNase treatment may be inadvisable, because the additional
manipulation could result in loss of RNA. The amplification of potential
contaminating genomic DNA can be precluded by designing transcript-specificprimers, for example, primers that span or amplify across splice junctions.

5.2.3 Analyzing Nucleic Acid Quantity and Quality
Accurate nucleic acid quantification is essential for gene expression analysis,
especially if total RNA amounts are used to normalize target gene expression.
RNA concentrations and purity are commonly determined by measuring the ratio of
the UV absorbance at 260 nm and 280 nm. The overall sensitivity of this method islow, especially for relatively dilute samples, and it doesn’t indicate the quality of theRNA. To determine the quality and quantity of your sample, we recommend using
the Experion™ automated electrophoresis system (see Product Guide). Examples ofa high-quality total RNA preparation and a poor-quality total RNA preparation are
shown in Figure 5.2.
A

B

Fig. 5.2. RNA quality assessed by an Experion electrophoresis system. A, An example of a highquality total RNA preparation showing distinct peaks for the 18S and 28S rRNA; B, an example of apoor-quality total RNA preparation where only small, degraded fragments are observed.

48© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegene expression analysis
cDNA template preparation (reverse transcription)

5.3 cDNA Template Preparation(Reverse Transcription)
Two methods are available for quantification of gene expression by RT-qPCR:“two-step” RT-qPCR or “one-step” RT-qPCR. In both cases, RNA is reverse
transcribed into cDNA, and the cDNA is then used as the template for quantitative
PCR amplification. “One-step” and “two-step” refers to whether the reverse
transcription and real-time PCR amplification are done in the same or separate
tubes. In the two-step method, RNA is first transcribed into cDNA in a reaction
using reverse transcriptase. An aliquot of the resulting cDNA can then be used asa template source for multiple qPCR reactions. In the one-step method, reverse
transcription and qPCR are performed in the same tube.
In two-step RT-qPCR, the RT step can be primed with oligo(dT) primers, random
primers, a mixture of the two, or gene-specific primers. One-step RT-PCR mustbe performed using gene-specific primers, and can be achieved either by using
Thermus thermophilus (Tth) polymerase, a DNA polymerase with inherent RT
activity, or by a two-enzyme system combining a reverse transcriptase with athermostable DNA polymerase. Since Tth DNA polymerase is derived from athermophilic bacterium, higher temperatures (>60ºC) can be used for the RT step,which can minimize secondary structure in high-GC-content mRNAs.
Accurate analysis of gene expression requires good reproducibility of reverse
transcription reactions. The robustness of a reverse transcription is determined by
the sensitivity, dynamic range, and specificity of the reverse transcriptase used.
Reverse transcriptases from Moloney murine leukemia virus (MMLV) and avian
myeloblastoma virus (AMV) are the most commonly used enzymes. When longor full-length cDNA transcripts are needed, MMLV reverse transcriptase and its
derivatives are better choices than AMV reverse transcriptase due to their lower
RNase H activity. It is has been observed, however, that RT reactions performed
with RNase H– reverse transcriptases sometimes require subsequent RNase H
treatment to effectively amplify certain templates and those at low concentrationin the PCR.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

49

gene expression analysis
qPCR assay development

As noted above, the reverse transcription step in two-step RT-qPCR can be
performed using oligo(dT) primers, random primers, a mix of these two, or genespecific primers. The choice of primers may influence quantification of your target
gene. Gene-specific primers give less background priming than oligo(dT) or
random primers. If you choose oligo(dT) primers for reverse transcription, you may
want to place PCR primers close to the 3' end of the transcript to avoid loss of
sensitivity due to truncated messages; this is especially important for longer
transcripts. Oligo(dT) priming should be avoided if you are working with transcripts
or species that have short poly(A) tails or lack them altogether. For the 5'-nucleaseassay, we found oligo(dT)–primed cDNA to perform very well; however, randomprimed cDNA performed equally well or slightly better for most sequences, andmuch better for some sequences. For most PCR applications, we have found best
performance using iScript™ and iScript™ Select cDNA synthesis kits, which employ
an MMLV RT (see Product Guide).

5.4 qPCR Assay Development
Gene expression analyses may be performed as singleplex or multiplex assays,using many different types of chemistries. Your experimental design will depend on
both practical and scientific considerations. Some factors to consider when
deciding between singleplex and multiplex assays are discussed in Section 2.2.1.
For singleplex assays, any chemistry listed in Section 2.2.2 can be used. For
multiplex assays, one must use a fluorescent primer- or probe-based chemistry,
such as those listed in Section 2.2.2.2; dsDNA binding dyes are not compatible
with multiplex assays.
Details on how to design and optimize singleplex and multiplex TaqMan assays are
given in Section 2.4 and Section 3; refer to those sections for details on assay
development and optimization. Note that for gene expression experiments, primers
should be designed to span splice junctions to avoid amplifying genomic DNA.

50

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegene expression analysis
experimentation

5.5 Experimentation
To determine the expression of the three target genes, ODC, OAZ, and AZI, andthe reference gene, β-actin, in samples A and B, these four genes were assessedin a multiplex two-step RT-qPCR assay.

5.5.1 Reaction Components for Multiplex Assay
The multiplex assay contained the following components in a 50 µl reaction:
1/10 of a reverse transcription reaction that used 100 ng of total RNA
300 nM each primer
200 nM each probe
200 µM each dNTP
5 mM MgCl2
3.75 U iTaq™ DNA polymerase

5.5.2 Cycling Protocol
The cycling program used is shown below:
Cycle 1

1 repeat

Cycle 240 repeats

95°C for 3 min

Step 195°C for 10 sec

Step 259°C for 60 sec (data collection)© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

51

gene expression analysis
gene expression data analysis

5.6 Gene Expression Data Analysis
The relative expression of ODC, OAZ, and AZI, with β-actin as the reference gene,
was determined using the 2-∆∆CT (Livak) method described in Section 4.2.3.1.
Results are shown in Table 5.1. Amplification efficiencies for all four genes werepreviously shown to be equal and >99.5%. Because all four genes were assayed ina single reaction, the β-actin gene and each of the three target genes, ODC, AZI,and OAZ, could be considered paired data points; therefore, ∆CT between thereference and target genes was first calculated for each replicate, and thenaveraged across the three replicates. The average ∆CT for each target gene fromthe two tissue samples was then used to calculate ∆∆CT, and this, in turn, wasused to calculate the fold difference of the three target genes between the two
samples. The respective levels of ODC, AZI, and OAZ were found to be 7.0–8.0fold, 2.8–3.7-fold, and 3.0–3.5-fold higher in sample B relative to sample A.
Table 5.1. Relative quantification of ODC, OAZ, and AZI in sample B relative
to sample A.
CT Values
β-Actin

ODC

AZI

OAZ

20.3
20.2
20.3

27.9
28.0
27.9

25.8
25.9
26.0

24.0
24.2
24.0

7.6 ± 0.1

5.6 ± 0.1

3.8 ± 0.1

25.5
25.4
25.6

24.9
24.7
24.6

22.9
23.0
22.9

4.7 ± 0.1

3.9 ± 0.2

2.1 ± 0.1

Sample B ∆CT – Sample A ∆CT–2.9 ± 0.1–1.7 ± 0.2–1.7 ± 0.1

Fold difference (2–∆∆C )7.0–8.0

2.8–3.7

3.0–3.5

SampleA

Replicate 1
Replicate 2
Replicate 3

Average ∆CT
B

Replicate 1
Replicate 2
Replicate 3

20.8
20.8
20.9

Average ∆CTT

52© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

Genotyping/Allelic
Discrimination
Experimental Design

55

Primer and Probe Design Using TaqMan Probes

56

DNA Extraction and Sample Preparation

57

Reaction Components When Using TaqMan Probes

58

Optimization

59

Cycling Protocol Using TaqMan Probes

59

Allelic Discrimination Data Analysis

59

Validation of Allelic Discrimination Assay

59

Genotype Assignments

72

genotyping/allelic discrimination
experimental design

6. Genotyping/Allelic
Discrimination
Single nucleotide polymorphisms (SNPs) are DNA sequence variations commonly
found among individuals as a result of single base-pair substitutions. In general,an allelic sequence variation is considered a DNA polymorphism if more than one
allele is found at a single locus with a frequency greater than 1% in the humanpopulation. DNA sequence variations play important roles in many processes,
such as an individual’s susceptibility to diseases and his or her response to drug
therapies. SNPs are also useful in investigating the contributions of individual genes
to diseases that have a complex multigene basis.
The identification of SNPs, and hence the study of human variation and diseases,
has been facilitated by the development of molecular tools to determine DNAchanges. SNP detection, genotyping, or allelic discrimination can be performedby methods such as allele-specific PCR, allele-specific primer extension,oligonucleotide ligation assay, and single-strand conformational polymorphism(SSCP) analysis. More recently, SNP genotyping methods based on real-time PCR
have gained popularity in research and diagnostic laboratories. Real-time PCRtechnologies have many advantages over traditional methods of genotyping,including higher throughput, decreased risk of crossover contamination, andreduced labor.
In this chapter, we provide general guidelines for allelic discrimination using realtime PCR with TaqMan probes. A sample protocol for genotyping two risk factorsof venous thrombosis in Caucasians is shown. The assay can be adapted easily todetect other SNPs.

54© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
experimental design

6.1 Experimental Design
Genotyping and SNP detection assays using real-time PCR may be designed inmany ways and with different probe-based chemistries (see Section 2.2.2.2),
including TaqMan probes and molecular beacons. Below we discuss how
TaqMan probes can discriminate between allelic variants, and we present special
considerations for allelic discrimination with TaqMan probes, including primer andprobe design, multiplexing, and validation.
How are TaqMan probes used to discriminate between allelic variants? The
TaqMan probes used for allelic discrimination are differentially labeled fluorescentprobes that are specific for each allele. One probe is specific for the wild-type (WT)
allele and another probe is specific for an allelic variant. The probes are differentiallylabeled with a 5' fluorescent reporter dye and the appropriate 3' quencher(see Section 2.4.1 for reporter and quencher selection). As shown in Figure 6.1,
the preferential hybridization of a perfectly matched probe versus a mismatchedprobe permits discrimination between the allelic variants. The matched TaqMan
probe specifically hybridizes to the amplicon during the combined annealing/extension step, and the 5' exonuclease activity of the DNA polymerase cleaves
off the fluorophore, separating it from the quencher to release a fluorescent signal
for the matched allelic variant. The unbound probe of the mismatched allelicvariant is not cleaved and remains quenched. The number of allelic variants
detected will depend on your experimental design and the number of fluorescentdyes supported by your real-time instrument. The iCycler iQ®, Chromo4™, and iQ™5
systems are capable of simultaneously monitoring up to four different dyes and thus
can discriminate up to four allelic variants using fluorescent allele-specific probes.
Match

Mismatch
R2

R1

C

T

Q1

G

G

Extension

Extension

R1

R2

C

R1 Reporter 1

Quencher 1

No fluorescence
T

Q1

G

Q1

Q2

Q2

G

R2 Reporter 2
Q2

Quencher 2

Fig. 6.1. Mechanism of allelic discrimination using TaqMan assay.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

55

genotyping/allelic discrimination
primer and probe design using TaqMan probes

As mentioned above, assays for genotyping or SNP detection by real-time PCR
may be designed in a variety of ways and will depend on your experimental
system. For simple discrimination of two to four SNPs at a single nucleotide
position using TaqMan probes, you would need to design a primer pair to amplify
one amplicon and two to four allele-specific probes, each with a different
fluorescent label. To detect SNPs at multiple nucleotide positions, single or multiple
amplicons may be used. For example, a multiplex assay can be designed tocoamplify two regions, and two allele-specific probe pairs would discriminate SNPs
in each amplicon.
Below we describe a multicolor, multiplex real-time PCR assay using TaqMan
probes for the simultaneous discrimination of allelic variants of the two mostcommon genetic risk factors for venous thrombosis in Caucasians, factor V
Leiden (FVL) and prothrombin (PT) G20210A mutations. This single-tube multiplex
assay employs: 1) two primer pairs to simultaneously amplify sequences fromthe coagulation factor V gene (which has the FVL G1691A mutation) and from thecoagulation factor II gene (which has the PT G20210A mutation), and 2) two pairsof allele-specific probes; each probe pair discriminates between the WT and themutant allele for each target.

6.2 Primer and Probe Design
Using TaqMan Probes
The guidelines presented in this section for primer and TaqMan probe design forallelic discrimination differ somewhat from the general guidelines in Section 2.4.1.
To design primers for the allelic discrimination assays described here, we used
Oligo 6 software (Molecular Biology Insights, Inc., Cascade, CO) and followed thegeneral guidelines in Section 2.4.1 of this guide (avoid primer-dimers, hairpins,
and self-complementary sequences), except that primers were designed with a
Tm of ~55°C. Primers were also designed to be compatible in a multiplex PCR
reaction (that is, they were designed to have similar Tm values and to avoid
complementarity between all primers and probes; see Section 3.1). We designed
two primer sets to coamplify a 97 bp sequence from the coagulation factor V gene
and a 111 bp sequence from PT; each amplicon spanned the region to be
genotyped (FVL and PT G20210A mutations). The primers used to amplify the
coagulation factor V gene were: forward, 5'-TCT GAA AGG TTA CTT CAA GGA C3' and reverse, 5'-ATC GCC TCT GGG CTA ATA-3'. The primers used to amplify
PT were: forward, 5'-TTG TGT TTC TAA AAC TAT GGT TCC-3' and reverse,
5'-AGT AGT ATT ACT GGC TCT TCC T-3'.

56© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
DNA extraction and sample preparation

For allelic discrimination, allele-specific TaqMan probes should be designed sothat the probe for the matching allelic variant binds the target with high specificity,while the probe for the mismatched allelic variant should not bind. We have foundthat WT and mutant alleles can be effectively discriminated by designing probesthat are short (Tm ~55°C) and by placing the polymorphic nucleotide in the middleof the probe. Note that these probe design rules differ from those suggested by
Livak (1999) and those discussed in Section 2.4.1 (probes with a Tm of ~65–67°C,
length ~23–26 bases; primers with a Tm of 58–60°C). Although probes with highTm values work well for quantitative experiments, we recommend shorter TaqMan
probes for allelic discrimination.
To detect the FVL and PT G20210A allelic variants, we designed probes
complementary to sequences that span the mutations in the targets. Probes
were designed to be relatively short (17–19 bases, Tm = 55 ± 1.5°C), and thepolymorphic nucleotide was placed in the center of the probes. Probes that
discriminated between the coagulation factor V wild-type and the FVL mutant allele
were 5'-[FAM]-TGG ACA GGC GAG GAA TAC-[Black Hole Quencher 1]-3' (forcoagulation factor V wild type), and 5'-[TET]-TGG ACA GGC AAG GAA TAC A[Black Hole Quencher 1]-3' (for FVL G20210A mutant). Probes that discriminatedbetween the PT wild type and G20210A mutant allele were labeled with 5'-[TAMRA]CTC TCA GCG AGC CTC AA-[Black Hole Quencher 2]-3' (for PT wild type), and5'-[Texas Red]-ACT CTC AGC AAG CCT CAA-[Black Hole Quencher 2]- 3' (for PT
G20210A mutant).

6.3 DNA Extraction andSample Preparation
For SNP analysis and genotyping, human genomic DNA is typically prepared fromwhole blood, cell lines, or tissues (for detection of tumor mutations). We prepare
our genomic DNA templates using either the AquaPure™ genomic DNA blood kit or
the InstaGene™ matrix (see Product Guide). To facilitate the denaturation of intact,high molecular weight genomic DNA, you may need to prepare your genomic DNA
template using the following steps: 1) digest with a restriction enzyme that does not
cut within the region to be amplified, and/or 2) boil DNA stock for 10 min and place
immediately on ice.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

57

genotyping/allelic discrimination
reaction components using TaqMan probes

For the assay described here, whole blood samples from 52 individuals withFVL and PT G20210A genotypes previously determined by PCR-RFLP wereused for the preparation of human genomic DNA using standard procedures.
DNA concentrations and purity are generally measured by spectrophotometry(ratio of the UV absorbance at 260 nm and 280 nm) or a nucleic-acid dye-binding
assay (e.g., Hoechst dye or PicoGreen for double-stranded DNA) and afluorometer, such as the VersaFluor™ fluorometer (see Product Guide).
Approximately 10 ng of DNA was used for each multicolor, multiplex reaction
described here.

6.4 Reaction Components When Using
TaqMan Probes
Although we added the individual components for the TaqMan allelic discrimination
assay described here separately, preformulated PCR master mixes containing
buffer, DNA polymerase, and dNTPs, such as iQ™ supermix, may also be used.
Each reaction contains: 1) two primer sets (total of four primers) to coamplify
sequences of the coagulation factor V gene and the PT gene, and 2) two pairs ofdifferentially labeled allele-specific probes (total of four probes) to specifically detect
WT and mutant alleles for each gene. Reaction components for the multiplex
TaqMan allelic discrimination assay described here and their final concentrations
are listed below:
10 ng DNA template
400 nM each primer
400 nM each probe
200 µM each dNTP
3 mM MgCl2
20 mM Tris-HCl, pH 8.4
50 mM KCl
2.25 U iTaq™ DNA polymerase
Sterile, nuclease-free water to final volume of 25.0 µl
We recommend that you prepare a reaction master mix containing enoughreagents to genotype the unknown DNA samples and controls, plus an excess tocover potential pipetting errors. For the most robust results, we also recommend
genotyping at least three replicates of each of your controls (WT alleles, mutant
alleles, and no-template control).

58© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
cycling protocol using TaqMan probes

6.5 Optimization
To determine the annealing temperature that would yield the highest specificsignals for each allele-specific probe, we took advantage of the gradient feature of
the iCycler iQ® real-time PCR detection system. Wild-type and mutant control
DNAs for each gene coagulation factor (V and PT), along with a no-templatecontrol, were tested in a temperature gradient optimization experiment. We
examined eight temperatures, ranging from 55 to 70°C, in a single experiment.
For this multiplex PCR reaction, we found that a combined primer/probe annealing
and extension at 58°C for 45 sec gave the best discrimination between the allelicvariants tested (data not shown).

6.6 Cycling Protocol Using
TaqMan Probes
Coamplification of sequences that cover the FVL and the PT G20210A mutations
was performed on the iCycler iQ system according to the protocol below.
Fluorescence data generated by cleavage of the matching allele-specific probes
were collected during the annealing/extension step at 58°C.
Cycle 1

1 repeat

Cycle 250 repeats

95°C for 3.5 min

Step 195°C for 10 sec

Step 258°C for 45 sec (data collection)

6.7 Allelic Discrimination Data Analysis
6.7.1 Validation of Allelic Discrimination Assay
We analyzed DNA from individuals with WT and mutant genotypes for FVL andPT G20210A mutations; the six possible outcomes are shown in Figures 6.2–6.7.
A WT individual (Figure 6.2) shows a fluorescent signal for both WT probes but
not for their mutant counterparts (FVL and PT G20210A). An individual who
is homozygous for one of the two mutations (Figures 6.3 and 6.4) shows afluorescent signal with the probe complementary to the mutant sequence but notwith its WT counterpart, and another fluorescent signal with the other WT probe
but not with its mutant counterpart. Individuals who are heterozygous for a single
target generate a fluorescent signal with both probes for that target (Figures 6.5
and 6.6). Compound heterozygous individuals generate fluorescent signals with all
four probes (two WT probes and two mutant counterpart probes; see Figure 6.7).
© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

59

genotyping/allelic discrimination
allelic discrimination data analysis

FVL WT probe/FAM

PT G20120A WT probe/TAMRA

Fig. 6.2. WT genotype.

60© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
allelic discrimination data analysis

FVL mutant probe/TET

PT G20210A mutant probe/Texas Red© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

61

genotyping/allelic discrimination
allelic discrimination data analysis

FVL WT probe/FAM

PT G20120A WT probe/TAMRA

Fig. 6.3. Homozygous mutant FVL.

62

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
allelic discrimination data analysis

FVL mutant probe/TET

PT G20210A mutant probe/Texas Red© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

63

genotyping/allelic discrimination
allelic discrimination data analysis

FVL WT probe/FAM

PT G20120A WT probe/TAMRA

Fig. 6.4. Homozygous mutant PT G20210A.

64© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
allelic discrimination data analysis

FVL mutant probe/TET

PT G20210A mutant probe/Texas Red© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

65

genotyping/allelic discrimination
allelic discrimination data analysis

FVL WT probe/FAM

PT G20120A WT probe/TAMRA

Fig. 6.5. Heterozygous genotype FVL G1691A.

66© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
allelic discrimination data analysis

FVL mutant probe/TET

PT G20210A mutant probe/Texas Red© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide67

genotyping/allelic discrimination
allelic discrimination data analysis

FVL WT probe/FAM

PT G20120A WT probe/TAMRA

Fig. 6.6. Heterozygous genotype PT G20210A.

68© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
allelic discrimination data analysis

FVL mutant probe/TET

PT G20210A mutant probe/Texas Red© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide69

genotyping/allelic discrimination
allelic discrimination data analysis

FVL WT probe/FAM

PT G20120A WT probe/TAMRA

Fig. 6.7. Compound heterozygous genotype FVL and PT G20210A.

70© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
allelic discrimination data analysis

FVL mutant probe/TET

PT G20210A mutant probe/Texas Red© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide71

genotyping/allelic discrimination
allelic discrimination data analysis

To examine the reproducibility of the four-color assay, six DNA samples fromindividuals with known genotypes (WT, FVL homozygous mutant, PT G20210A
homozygous mutant, FVL heterozygous, PT G20210A heterozygous, and FVL/PT
G20210A compound heterozygous) and a no-template control were tested in fiveexperiments. For all cases, assays of the samples gave consistent andunambiguous genotypes.

6.7.2 Genotype Assignments
Genotypes can be assigned by analyzing the amplification plots generated for eachallele-specific probe or by using the allelic discrimination analysis module available
in the software of many real-time instruments, including the iCycler iQ, DNA Engine
Opticon® 2, the Chromo4, and the iQ5 systems (see Product Guide). After the
real-time PCR amplifications are finished, the iCycler iQ, iQ5 and Opticon Monitor™
software packages can assign genotypes using an algorithm that takes into
account the signal from the assigned WT and homozygous mutant controls. Thesesoftware packages can analyze either the final relative fluorescent units (RFU) or theCT values and graph the data as a scatter plot.
For the multicolor, multiplex assay described here, genotypes for each gene wereassigned by the iCycler iQ software using the RFU mode and are shown on
separate plots. Figure 6.8 shows the genotype assignments for the coagulation
factor V gene, with four clearly defined clusters shown on the plot. The first cluster
consists of samples with FAM signal values (x-axis) within 1,050–1,700 RFU andrepresents individuals with the WT genotype. The second cluster includes samples
with TET signal values (y-axis) within 1,000–1,600 RFU and represents individuals

Fig. 6.8. Coagulation factor V genotyping with the multicolor, multiplex TaqMan assay.
The normalized fluorescence values of FAM (WT probe) vs. TET (FVL mutant probe) are shown.

72© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenotyping/allelic discrimination
allelic discrimination data analysis

with the FVL homozygous mutant genotype. The third cluster (FVL heterozygous
individuals) includes samples with FAM and TET signal values within 300–1,100
RFU. The last cluster represents samples with very low RFU values for both FAM
and TET; these are the no-template controls. Similarly, Figure 6.9 shows the PT
genotypes in four well-defined clusters. The genotyping results generated by themultiplex four-color assay and analyzed by the software were in agreement with theresults of an RFLP genotyping assay (data not shown).

Fig. 6.9. PT genotyping with the multicolor, multiplex TaqMan assay. The normalized fluorescencevalues of TAMRA (WT probe) vs. Texas Red (PT mutant probe) are shown.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

73

74

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

Genetically Modified
Organism (GMO)
Detection
Experimental Design

77

DNA Extraction and Sample Preparation for GMO Detection

77

GM Soy Detection Using a Singleplex
SYBR Green I qPCR Assay

78

Reaction Components

78

Cycling Protocol

79

Data Analysis

79

GM Soy Detection Using a Multiplex TaqMan qPCR Assay

81

Reaction Components

82

Cycling Protocol

82

Data Analysis

82

genetically modified organism (GMO) detection

7. Genetically Modified
Organism (GMO) Detection
GMOs are typically engineered to confer beneficial traits ranging from enhanced
nutritional value to resistance to herbicides and pests. Soy, corn, and cotton are
the most common genetically modified (GM) crops. Controversy over GMO-derived
food has led some countries to require the disclosure and labeling of GMO content
on foods. As a result, accurate and reliable methods to detect GMOs are needed.
Current methods to detect GMOs include PCR-based methods and enzyme-linked
immunosorbent assays (ELISAs). Although ELISAs are relatively inexpensive andrapid, PCR-based methods offer the additional advantages of high sensitivity andaccuracy, robustness, and the option to detect GMOs quantitatively as well as
qualitatively. Real-time qPCR, for example, can be used to determine thepercentage of GMO in a food sample.
Herbicide-resistant soy is an example of a GM food crop. Resistance to theherbicide glyphosate is conferred by introducing a transgene that restores anessential amino acid pathway disrupted by glyphosate. The transgene is aglyphosate-tolerant version of the enolpyruvylshikimate-3-phosphate synthase(epsps) gene from the soil bacterium Agrobacterium sp. strain cp4. Expression of
cp4 epsps in modified plants, such as Roundup Ready soybeans, confers
glyphosate resistance, and thus allows the use of glyphosate on fields growing
these GM crops.
The cp4 epsps gene is expressed from the cauliflower mosaic virus (CaMV) 35S
promoter. The CaMV 35S promoter is often used in GM crops because it has welldefined sequence requirements, is expressed in a broad range of tissues, and does
not need any viral trans-acting factors. Because of its prevalent use in genetic
modification of crops, the CaMV 35S promoter is a useful target for qPCR
designed to detect a range of GMOs.
In this section, we provide protocols to detect glyphosate-resistant soy from foodsamples using real-time PCR. The advantages of the methods described here
include the ability to test multiple samples, the need for only small amounts ofstarting material, applicability to raw and processed foods, and adaptability forother GM crops, such as corn, rice, and peanuts.

76© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenetically modified organism (GMO) detection
experimental design

7.1 Experimental Design
Two real-time PCR methods for detecting and quantifying GM soy in foods arepresented here. (See Section 2.2.2 for a discussion of real-time chemistries(SYBR Green I and TaqMan), and Section 2.2.1 for singleplex and multiplex
considerations.) The first protocol is a one-color (singleplex) assay that uses SYBRGreen I to detect a GMO-specific sequence (a transgene conferring herbicide
resistance) and an endogenous reference sequence (soy lectin) in separate,
parallel reactions. The second protocol is a two-color multiplex assay that uses
differentially labeled TaqMan probes: one to detect the GMO-specific promoter(the CaMV 35S promoter) sequence and the other to detect an endogenous
reference sequence (soy lectin), where both reactions are carried out in a single
reaction vessel. An endogenous soy reference gene was used to normalize theamount of GM soy to the total amount of soy in the sample. The amount of GM
soy was quantified by interpolation using a standard curve generated from a
set of certified reference standards, as discussed in detail in the Data Analysis
section below.

7.2 DNA Extraction and Sample
Preparation for GMO Detection
Reference standards used were dried soybean powder containing mass fractionsof 0–5% Roundup Ready soybean (Sigma). These reference standards wereprepared by the manufacturer by mixing dried non-GM soybean powder withRoundup Ready soybean powder. The food samples tested (soy burger, soydessert, and two brands of soy flour) were obtained from a supermarket.
Dry samples, the reference standards and the soy flour, were used directly in
the DNA isolation procedure, whereas wet samples, the soy burger and the soy
dessert, were mashed to a fine, homogeneous paste with a mortar and pestle.
For the real-time PCR assays described in Sections 7.3 and 7.4, the DNA
templates were prepared from reference standards and food samples using the
DNeasy plant mini kit (Qiagen) using methods described in the kit protocol.
DNA concentrations were determined by spectrophotometry and the quality
verified by electrophoresis on a 1% agarose gel. Generally, we obtained 1–2 µg of
DNA from 55–100 mg of each food sample.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide77

genetically modified organism (GMO) detection
GM soy detection using a singleplex SYBR Green I qPCR assay

7.3 GM Soy Detection Using aSingleplex SYBR Green I qPCR Assay
After DNA was isolated from food and reference samples as described in Section
7.2, the fraction of glyphosate-resistant soy in soy-based food samples wasdetermined using the singleplex SYBR Green I qPCR assay described in thissection. This assay detects a GMO-specific sequence, which is from theAgrobacterium cp4 epsps gene, and an endogenous genomic DNA control
sequence from the soy lectin gene, which is expressed in both GM and unmodified
soy. Since SYBR Green I fluorescence is not target-specific and cannot
discriminate between the GMO-specific target and the endogenous soy target,
amplification of these targets was performed in separate wells in parallel, singleplex
reactions. (See Section 2.2.2 for a discussion of real-time chemistries (SYBR Green I),
and Section 2.2.1 for singleplex and multiplex considerations.) The percent GMO,
which is a fraction of the total soy content in the soy-based food samples, isdetermined by comparison to reference standards and can be quantified down toapproximately 0.5% (w/w) concentration in this assay using these standards.

7.3.1 Reaction Components
To amplify the GMO-specific sequence (a 356 bp region of the cp4 epsps gene),
the primers used were: forward, 5'-TGG CGC CCA AAG CTT GCA TGG C-3' andreverse, 5'-CCC CAA GTT CCT AAA TCT TCA AGT-3'. To amplify the endogenous
control, a 318 bp region of the soy lectin gene, which is expressed in both GM andnon-GM soy, the primers were: forward, 5'-GAC GCT ATT GTG ACC TCC TC-3'
and reverse, 5'-GAA AGT GTC AAG CTT AAC AGC GAC G-3'.
Although the components in the SYBR Green I assay described here were added
individually, preformulated PCR master mixes containing buffer, DNA polymerase,dNTPs, and SYBR Green I dye, such as iQ™ SYBR® Green supermix, may also be
used. Reaction components for the singleplex SYBR Green I assays describedhere and their final concentrations are listed below. Separate reactions wereassembled to amplify the GMO-specific cp4 epsps gene and the soy lectin
endogenous control gene, using the respective primers listed above.
100 ng/µl DNA
250 nM of each primer
200 µM dNTPs
2 mM MgCl21x Mg2+-free buffer
0.5x SYBR Green I
0.02 U/µl DyNAzyme II DNA polymerase (Finnzymes)
Sterile, nuclease-free water to final volume of 20.0 µl
78© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenetically modified organism (GMO) detection
GM soy detection using a singleplex SYBR Green I qPCR assay

7.3.2 Cycling Protocol
Parallel amplification of GMO-specific cp4 epsps and the soy lectin sequenceswere performed on the DNA Engine Opticon® 2 system using the protocol below:
1. 94°C, 3 min
2. 94°C, 10 sec
3. 60°C, 15 sec
4. 72°C, 20 sec
5. 86°C, 2 sec
6. Plate read
7. Go to step 2, 39 more times
8. 72°C, 10 min
9. Melt-curve analysis: 65°C to 98°C, 0.2°C/read, 1 sec hold10. 72°C, 10 min
End7.3.3 Data Analysis
Because the assay described here uses SYBR Green I, we verified that each target
was specifically amplified (i.e., no nonspecific amplicons were produced) by meltcurve analysis, which showed a single peak for each amplicon (data not shown).
See Section 2.2.2.1 for details on how melt-curve analysis can be used to analyze
the specificity of a SYBR Green I-based qPCR assay.
The percent GM soy content of food samples was calculated in three steps:
1) GM soy was normalized to total soy content, yielding ∆CT, 2) a standard curve
was generated using the reference standards (∆CT vs. log %GMO), and 3) thepercent of GM soy in food samples was calculated by interpolation of the ∆CTvalues of the normalized samples using the standard curve. Details for each step
are given below:
1. GM soy was normalized to total soy by calculating the ∆∆CT value. The CTfrom the control amplification (soy lectin) was subtracted from the CT of the
GMO-specific amplification (epsps). For standards and samples that did notamplify a product with the epsps primers, the ∆CT value was designated as
not detected (ND).
∆CT = CT(GMO epsps) – CT(lectin)
The use of the ∆CT assumes that the two reactions have similar efficiencies andthat they proceed in a mutually independent manner since they were carried out inseparate wells.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

79

genetically modified organism (GMO) detection
GM soy detection using a singleplex SYBR Green I qPCR assay

Table 7.1. Calculation of ∆CT = CT(epsps) – CT(lectin)Standard sample

CT(epsps)

CT(lectin)∆CT

0.0% GMO standard
0.1% GMO standard
0.5% GMO standard
1.0% GMO standard
2.0% GMO standard
5.0% GMO standard
Soy dessert
Soy flour
Soy burger

ND
ND
26.85
25.62
24.56
22.94
22.78
ND
22.32

19.68
19.78
19.58
19.52
19.70
19.48
19.27
18.13
19.91

ND
ND
7.27
6.10
4.86
3.46
3.51
ND
2.41

2. A standard curve was generated using the reference standards: the ∆CTvalue of the reference standards were plotted on the x-axis and the log %GMO
of the standards were plotted on the y-axis. Figure 7.1 shows the reference
standards for 0–5% GMO. Data from the reference standards were fitted to aline using the Microsoft Excel chart function “Add Trendline”. The function also
returns the R2 value, which indicates how well the linear equation fits the data.
0.80

y = –0.261x + 1.592

0.60

R2 = 0.999
log %GMO

0.40

0.20

0.00

–0.20

–0.40
0.00

2.00

4.00

6.00

8.00

∆CT
Fig. 7.1. Standard curve generated from the ∆CT values of the soy reference standards.
The log %GMO in each standard is shown. The R2 value was 0.999.

80© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenetically modified organism (GMO) detection
GM soy detection using a multiplex TaqMan I qPCR assay

Table 7.2. Determination of percent GM soy.
Sample∆CT%GMO

Soy dessert
Soy flour*
Soy burger*

2.1
ND
0.7

4.40
0–0.5
>5

* These were outside the range of concentrations of the standards.

3. The percent of GM soy in test food samples was calculated by interpolation
using the standard curve with the least-squares method using the Trend function
in Excel software. In the Trend function, the following values were specified forthe standards: log %GMO (the known y values), ∆CT (the known x values), andthe ∆CT of the food sample for the new x. This function returned the value log%GMO of the food sample. The percent GMO soy content of the sample wasthen determined using the formula 10(log %GMO).

7.4 GM Soy Detection Using a
Multiplex TaqMan qPCR Assay
After DNA was isolated from food and reference samples as described in
Section 7.2, the fraction of glyphosate-resistant soy (i.e., GM soy) in soy-based
food samples was determined using another qPCR assay, the multiplex TaqMan
assay described in this section. This assay detects the GMO-specific sequence(a sequence from CaMV 35S promoter) and an endogenous control sequence
from the soy lectin gene, which is present in both GM and unmodified soy.
The sequence-specificity of TaqMan probes allows the amplification and detectionof more than one reaction in a single reaction vessel. In this single-tube assay,a FAM-labeled probe was used to detect the CaMV 35S promoter sequence,
while a VIC-labeled probe was used to detect soy lectin. (See Section 2.2.2 for a
discussion of real-time chemistries (TaqMan) and Section 2.2.1 for singleplex andmultiplex considerations.) The percent GM soy, which is a fraction of the total
soy content in the soy-based food samples, is determined by comparison toreference standards and can be quantified down to approximately 0.5% (w/w)
concentration in this assay.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

81

genetically modified organism (GMO) detection
GM soy detection using a multiplex TaqMan qPCR assay

7.4.1 Reaction Components
Components for the multiplex TaqMan assay for GM soy detection describedhere are listed below. The primers, probes, dNTPs, MgCl2, and buffer were froma preformulated kit (TaqMan GMO Soy 35S detection kit, Applied Biosystems).
The GMO-specific CaMV 35S promoter was amplified using GMO-specific primersand detected by a FAM-labeled probe, while the soy endogenous control gene wasamplified with lectin primers and detected with a VIC-labeled probe, in the same
reaction tube:
2.0 µl DNA
17.5 µl GMO kit mix (Applied Biosystems)
0.5 µl AmpliTaq Gold (Applied Biosystems)
20.0 µl final volume

7.4.2 Cycling Protocol
Amplifications of the GMO-specific CaMV 35S promoter and the soy lectinsequences were performed on the DNA Engine Opticon 2 system using theprotocol below:
1. 94°C, 9 min
2. 96°C, 20 sec
3. 60°C, 1 min
4. 72°C, 30 sec
5. Plate read
6. Go to step 2, 39 more times
End

7.4.3 Data Analysis
As described in Section 7.3.3, the percent GM soy content of food samples wascalculated in three steps: 1) GM soy was normalized to total soy content, 2) a
standard curve was generated using the reference standards (∆CT vs. log %GMO),
and 3) the percent of soy in food samples that was genetically modified was
calculated by interpolation of the ∆CT values of the normalized samples using
the standard curve. The analysis and results of the multiplex TaqMan assay are
as follows:
1. GM soy was normalized to total soy by calculating the ∆CT value. For standards
and samples that did not amplify a product with the CaMV primers, the ∆CTvalue was designated as “not detected” (ND).
∆CT = ∆CT(CaMV) – ∆CT(lectin)82© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidegenetically modified organism (GMO) detection
GM soy detection using a multiplex TaqMan qPCR assay

Table 7.3. Calculation of ∆CT = CT(epsps) – CT(lectin)Standard or Sample

CT(CaMV)

CT(lectin)∆CT

0.0% GMO standard
0.1% GMO standard
0.5% GMO standard
1.0% GMO standard
2.0% GMO standard
5.0% GMO standard
Soy burger
Soy flour

ND
35.96
33.19
32.12
31.34
29.76
27.22
ND

24.40
24.30
23.60
23.60
24.00
23.80
21.85
20.73

ND
11.66
9.59
8.52
7.34
5.96
5.37
ND

2. Generate a standard curve using reference standards. Figure 7.2 shows thereference standards for 0–5% GMO.
1.0

y = –0.295x + 1.592

log %GMO

0.5

R2 = 0.996

0

–0.5

–1.0

–1.5
0.00

5.00

10.00

15.00

∆CT
Fig. 7.2. Standard curve generated from the ∆CT values of the soy reference standards.
The log %GMO in each standard is shown. The R2 value was 0.996.

3. Determine GMO content of food samples by interpolation using thestandard curve.
Table 7.4. Determination of percent GM soy.
Sample∆CT%GMO

Soy burger*
Soy flour*

4.41
ND

>5
0–0.1

* These were outside the range of concentrations of the standards.

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

83

84

© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

Product
Guide
Real-Time PCR Detection Systems

86

Sample Preparation Reagents86

Sample Assessment

86

Reverse Transcription Kits

87

Real-Time Reagents88

Conventional PCR Reagents

88

Plastics

89

Software89

product guideReal-Time PCR Detection Systems
CFB-3120
MiniOpticon™ Real-Time PCR System, includes optical housing,
MJ Mini™ thermal cycler, analysis software
170-9770

MyiQ™ Single-Color Real-Time PCR Detection System, includes
iCycler® base, optics module, software CD-ROM, 96-well optical
reaction module, optical-quality 96-well PCR plates, Microseal® 'B'
seals, communication cables, power cords, instructions

170-9780

iQ™5 Multicolor Real-Time PCR Detection System, includes iCyclerbase, optics module, software CD-ROM, 5 installed filter sets,
96-well reaction module, calibration solutions, optical-quality
96-well PCR plates, Microseal 'B' seals, communication cables,
power cord, quick reference cards, instructions

CFB-3260G

Chromo4™ Four-Color Real-Time PCR Detector, includes opticalhousing, photonics shuttle, DNA Engine® thermal cycler, 96-wellsample block, analysis software

Sample Preparation Reagents732-6800
Aurum™ Total RNA 96 Kit, 2 x 96-well preps732-6820

Aurum Total RNA Mini Kit, 50 preps732-6470

Aurum Vacuum Manifold

732-6830

Aurum Total RNA Fatty and Fibrous Tissue Kit

Sample Assessment
700-7001
Experion™ System, 100–120 V, for RNA analysis, includes
electrophoresis station, priming station, vortex station, software,USB2 cable, test chip, instructions (analysis kits sold separately)86

700-7002

Experion System, 220–240 V, for RNA analysis, includes
electrophoresis station, priming station, vortex station, software,USB2 cable, test chip, instructions (analysis kits sold separately)

700-7103

Experion RNA StdSens Analysis Kit for 10 Chips, includes 10 RNA
StdSens chips, 1,250 µl RNA gel, 20 µl RNA StdSens stain, 20 µl
RNA ladder, 900 µl RNA StdSens loading buffer, 2 spin filters

700-7104

Experion RNA StdSens Analysis Kit for 25 Chips, includes 25 RNA
StdSens chips, 2 x 1,250 µl RNA gel, 2 x 20 µl RNA StdSens stain,
2 x 20 µl RNA ladder, 2 x 900 µl RNA StdSens loading buffer,
4 spin filters© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

product guide

700-7105

Experion RNA HighSens Analysis Kit for 10 Chips, includes 10
RNA HighSens chips, 1,250 µl RNA gel, 20 µl RNA HighSens
stain, 20 µl RNA ladder, 900 µl RNA HighSens loading buffer,
100 µl RNA sensitivity enhancer, 2 spin filters

700-7106

Experion RNA HighSens Analysis Kit for 25 Chips, includes 25
RNA HighSens chips, 2 x 1,250 µl RNA gel, 2 x 20 µl RNA
HighSens stain, 20 µl RNA ladder, 2 x 900 µl RNA HighSens
loading buffer, 2 x 100 µl RNA sensitivity enhancer, 4 spin filters

170-2402

VersaFluor™ Fluorometer, 100/120/220 V, includes one standard
cuvette holder, 100 standard disposable cuvettes, and a choice of
one excitation and one emission filter

170-2403

VersaFluor Fluorometer System, 120 V, includes same as
170-2402 with a 120 V thermal printer and cable

170-2404

VersaFluor Fluorometer System, 100 V, includes same as
170-2402 with a 100 V thermal printer and cable

Reverse Transcription Kits
170-8890
iScript™ cDNA Synthesis Kit, 25 x 20 µl reactions, includes 5x
iScript reaction mix, iScript enzyme, nuclease-free water
170-8891

iScript cDNA Synthesis Kit, 100 x 20 µl reactions

170-8896

iScript™ Select cDNA Synthesis Kit, 25 x 20 µl reactions, includes
5x iScript Select reaction mix, iScript reverse transcriptase,oligo(dT) mix, random primer mix, gene-specific primer (GSP)
enhancer solution, nuclease-free water

170-8897

iScript Select cDNA Synthesis Kit, 100 x 20 µl reactions

170-8892

iScript One-Step RT-PCR Kit With SYBR® Green, 50 x 50 µl
reactions, includes iScript reverse transcriptase forone-step RT-PCR, 2x SYBR Green RT-PCR reaction mix,
nuclease-free water

170-8893

iScript™ One-Step RT-PCR Kit With SYBR® Green,
200 x 50 µl reactions

170-8894

iScript One-Step RT-PCR Kit for Probes, 50 reactions

170-8895

iScript One-Step RT-PCR Kit for Probes, 200 reactions© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide87

product guideReal-Time Reagents
170-8880
iQ™ SYBR® Green Supermix, 100 x 50 µl reactions
170-8882

iQ SYBR Green Supermix, 500 x 50 µl reactions

170-8884

iQ SYBR Green Supermix, 1,000 x 50 µl reactions

170-8885

iQ SYBR Green Supermix, 2,000 x 50 µl reactions, 50 ml bottle

170-8860

iQ™ Supermix, 100 x 50 µl reactions

170-8862

iQ Supermix, 500 x 50 µl reactions

170-8864

iQ Supermix, 1,000 x 50 µl reactions

170-8848

iQ™ Multiplex Powermix, 50 x 50 µl reactions

170-8849

iQ Multiplex Powermix, 200 x 50 µl reactions

170-8850

iTaq™ SYBR® Green Supermix With ROX, 200 x 50 µl reactions

170-8851

iTaq SYBR Green Supermix With ROX, 500 x 50 µl reactions

170-8852

iTaq SYBR Green Supermix With ROX, 1,000 x 50 µl reactions

170-8853

iTaq SYBR Green Supermix With ROX, 2,000 x 50 µl reactions,
50 ml bottle

170-8854

iTaq™ Supermix With ROX, 200 x 50 µl reactions

170-8855

iTaq Supermix With ROX, 500 x 50 µl reactions

170-8856

iTaq Supermix With ROX, 1,000 x 50 µl reactions

170-8857

iTaq Supermix With ROX, 2,000 x 50 µl reactions, 50 ml bottle

170-8858

ROX Passive Reference Dye, 0.5 ml

Conventional PCR Reagents
170-8870
iTaq™ DNA Polymerase, 5 U/µl, includes 250 U polymerase,
1.25 ml 10x PCR buffer, 1.25 ml 50 mM MgCl2 solution

88170-8875

iTaq DNA Polymerase, 5 U/µl, includes 5,000 U polymerase,
25 ml 10x PCR buffer, 25 ml 50 mM MgCl2 solution

170-8874

dNTP Mix, 200 µl premixed solution, contains 10 mM each dNTP
(dATP, dCTP, dGTP, dTTP)© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide

product guide

Plastics
MSB-1001

Microseal 'B' Seals, clear adhesive, 100

223-9441

96-Well 0.2 ml Thin-Wall PCR Plates, 25

MLL-4851

Multiplate™ Low-Profile 48-Well Unskirted PCR Plates, 8 x 6
format, white, thin-wall polypropylene, 50

MLL-4801

Multiplate Low-Profile 48-Well Unskirted PCR Plates, 8 x 6 format,
natural color, thin-wall polypropylene, 50

Software170-8734
170-9753

Beacon Designer Probe/Primer Design Software, includes
CD-ROM, quick guide, instructions
iQ5 Optical System Software, version 2.0

170-9753SE01 iQ5 Optical System Software, Security Edition, single-seat license
170-9753SE05 iQ5 Optical System Software, Security Edition, 5-seat license
170-9753SE10 iQ5 Optical System Software, Security Edition, 10-seat license© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide89references and legal notices

References
Mathews DH et al., Expanded sequence dependence of thermodynamic parameters provides robust
prediction of RNA secondary structure, J Mol Biol 288, 910–940 (1999)
Rozen S and Skaletsky HJ, Primer3 on the WWW for general users and for biologist programmers, pp
365–386 in Bioinformatics Methods and Protocols: Methods in Molecular Biology (Krawetz S and MisenerS, eds), Humana Press, Totowa, NJ (2000); source code available at http://fokker.wi.mit.edu/primer3/
Zuker M et al., Algorithms and thermodynamics for RNA secondary structure prediction: a practical guide,
pp 11–43 in RNA Biochemistry and Biotechnology (Barciszewski J and Clark BFC, eds), Kluwer Academic
Publishers, Boston (1999)
Legal Notices
Amplifluor and UniPrimer are trademarks of Millipore Corporation. AmpliTaq, AmpliTaq Gold, and TaqMan
are trademarks of Roche Molecular Systems, Inc. BD QZyme is a trademark of Becton, Dickinson andCompany. Beacon Designer is a trademark of PREMIER Biosoft International. BHQ and Black Hole
Quencher are trademarks of Biosearch Technologies, Inc. Cy is a trademark of GE Healthcare. DNeasy isa trademark of Qiagen GmbH Corporation. DyNAzyme is a trademark of Finnzymes Oy. Eclipse is atrademark of Epoch Biosciences, Inc. Excel is a trademark of Microsoft Corporation. Hoechst is atrademark of Hoechst Aktiengesellschaft. LUX is a trademark of Invitrogen Corporation. Oligo is atrademark of Molecular Biology Insights, Inc. PicoGreen, SYBR, and Texas Red are trademarks of
Molecular Probes, Inc. Roundup Ready is a trademark of Monsanto Company. Scorpions is a trademarkof DxS Limited. VIC is a trademark of Applera Corporation.
Molecular beacons and their use are licensed under patents owned by The Public Health ResearchInstitute of the City of New York, Inc.
Primer3 includes software developed by the Whitehead Institute for Biomedical Research.
Bio-Rad Laboratories, Inc. is licensed by Molecular Probes, Inc. to sell reagents containing SYBR Green I
for use in real-time PCR, for research purposes only.
Notice regarding Bio-Rad thermal cyclers and real-time systems.
Purchase of this instrument conveys a limited non-transferable immunity from suit for the purchaser’s own
internal research and development and for use in applied fields other than Human In Vitro Diagnostics
under one or more of U.S. Patents Nos. 5,656,493, 5,333,675, 5,475,610 (claims 1, 44, 158, 160–163
and 167 only), and 6,703,236 (claims 1–7 only), or corresponding claims in their non-U.S. counterparts,
owned by Applera Corporation. No right is conveyed expressly, by implication or by estoppel under any
other patent claim, such as claims to apparatus, reagents, kits, or methods such as 5' nuclease methods.
Further information on purchasing licenses may be obtained by contacting the Director of Licensing,
Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.
Bio-Rad's real-time thermal cyclers are licensed real-time thermal cyclers under Applera's United States
Patent No. 6,814,934 B1 for use in research and for all other fields except the fields of human diagnostics
and veterinary diagnostics.

90© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidenotes© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide91

notes92© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidenotes© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide93notes94© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidenotes© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide95notes96© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidenotes© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide97notes98© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guidenotes© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications Guide99

notes100© 2006 Bio-Rad Laboratories, Inc. All rights reserved. Real-Time PCR Applications GuideBio-Rad
Laboratories, Inc.

Web site www.bio-rad.com USA 800 4BIORAD Australia 61 02 9914 2800
Austria 01 877 89 01 Belgium 09 385 55 11 Brazil 55 21 3237 9400
Canada 905 712 2771 China 86 21 6426 0808
Czech Republic 420 241 430 532 Denmark 44 52 10 00
Finland 09 804 22 00 France 01 47 95 69 65 Germany 089 318 84 0
Greece 30 210 777 4396 Hong Kong 852 2789 3300
Hungary 36 1 455 8800 India 91 124 4029300 Israel 03 963 6050
Italy 39 02 216091 Japan 03 5811 6270 Korea 82 2 3473 4460
Mexico 52 555 488 7670 The Netherlands 0318 540666
New Zealand 0508 805 500 Norway 23 38 41 30 Poland 48 22 331 99 99
Portugal 351 21 472 7700 Russia 7 495 721 14 04
Singapore 65 6415 3188 South Africa 27 861 246 723
Spain 34 91 590 5200 Sweden 08 555 12700 Switzerland 061 717 95 55
Taiwan 886 2 2578 7189 United Kingdom 020 8328 2000

Life ScienceGroup

Bulletin 5279

US/EG

Rev B

06-08061206

Sig 1106